<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Growth hormone for in vitro fertilisation (IVF) - Sood, A - 2021 | Cochrane Library</title> <meta content="Growth hormone for in vitro fertilisation (IVF) - Sood, A - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000099.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Growth hormone for in vitro fertilisation (IVF) - Sood, A - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000099.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD000099.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Growth hormone for in vitro fertilisation (IVF)" name="citation_title"/> <meta content="Akanksha Sood" name="citation_author"/> <meta content="St. Mary's Hospital, Manchester University Hospitals NHS Foundation Trust" name="citation_author_institution"/> <meta content="Gadha Mohiyiddeen" name="citation_author"/> <meta content="Sidra Medicine" name="citation_author_institution"/> <meta content="Gaity Ahmad" name="citation_author"/> <meta content="Pennine Acute Hospitals NHS Trust" name="citation_author_institution"/> <meta content="Cheryl Fitzgerald" name="citation_author"/> <meta content="St. Mary's Hospital, Manchester University Hospitals NHS Foundation Trust" name="citation_author_institution"/> <meta content="Andrew Watson" name="citation_author"/> <meta content="Tameside &amp; Glossop Acute Services NHS Trust" name="citation_author_institution"/> <meta content="Lamiya Mohiyiddeen" name="citation_author"/> <meta content="St. Mary's Hospital, Manchester University Hospitals NHS Foundation Trust" name="citation_author_institution"/> <meta content="lamiya.mohiyiddeen@mft.nhs.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD000099.pub4" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/11/22" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000099.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000099.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000099.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Abortion, Spontaneous; Fertilization in Vitro; *Growth Hormone [therapeutic use]; Live Birth [epidemiology]; Ovulation Induction; Pregnancy Rate; Sperm Injections, Intracytoplasmic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000099.pub4&amp;doi=10.1002/14651858.CD000099.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="QO4KtYGW";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD000099\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD000099\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","th","pt","ms","ja","hr","fa","fr","hu"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD000099.pub4",title:"Growth hormone for in vitro fertilisation (IVF)",firstPublishedDate:"Nov 22, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecology and Fertility Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=QO4KtYGW&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000099.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000099.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD000099.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD000099.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000099.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD000099.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;hu&quot;,&quot;title&quot;:&quot;Összefoglalás közérthető nyelven&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD000099.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD000099.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD000099.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD000099.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4214 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD000099.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-sec-0096"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-sec-0090"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/appendices#CD000099-sec-0101"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/supinfo/CD000099StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/supinfo/CD000099StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Growth hormone for in vitro fertilisation (IVF)</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/information#CD000099-cr-0004">Akanksha Sood</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/information#CD000099-cr-0005">Gadha Mohiyiddeen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/information#CD000099-cr-0006">Gaity Ahmad</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/information#CD000099-cr-0007">Cheryl Fitzgerald</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/information#CD000099-cr-0008">Andrew Watson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000099.pub4/information#CD000099-cr-0009"><i class="icon corresponding-author fa fa-envelope"></i>Lamiya Mohiyiddeen</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/information/en#CD000099-sec-0111">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 22 November 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD000099.pub4">https://doi.org/10.1002/14651858.CD000099.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD000099-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000099-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000099-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000099-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000099-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD000099-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD000099-abs-0006">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000099-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD000099-abs-0001" lang="en"> <section id="CD000099-sec-0001"> <h3 class="title" id="CD000099-sec-0001">Background</h3> <p>In an effort to improve outcomes of in vitro fertilisation (IVF) cycles, the use of growth hormone (GH) has been considered as adjuvant treatment in ovarian stimulation. Improving the outcomes of IVF is especially important for women with infertility who are considered 'poor responders'. We have compared the outcomes of IVF with adjuvant GH versus no adjuvant treatment in routine use, and specifically in poor responders. </p> </section> <section id="CD000099-sec-0002"> <h3 class="title" id="CD000099-sec-0002">Objectives</h3> <p>To assess the effectiveness and safety of growth hormone as an adjunct to IVF compared to standard IVF for women with infertility </p> </section> <section id="CD000099-sec-0003"> <h3 class="title" id="CD000099-sec-0003">Search methods</h3> <p>We searched the following databases (to November 2020): Cochrane Gynaecology and Fertility (CGF) Group specialised register, CENTRAL, MEDLINE, Embase, CINAHL, Epistemonikos database and trial registers together with reference checking and contact with study authors and experts in the field to identify additional trials. </p> </section> <section id="CD000099-sec-0004"> <h3 class="title" id="CD000099-sec-0004">Selection criteria</h3> <p>We included all randomised controlled trials (RCTs) of adjuvant GH treatment in IVF compared with no adjuvant treatment for women with infertility. We excluded trials where additional adjuvant treatments were used with GH. We also excluded trials comparing different IVF protocols. </p> </section> <section id="CD000099-sec-0005"> <h3 class="title" id="CD000099-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures recommended by Cochrane. Two review authors independently performed assessment of trial risk of bias and extraction of relevant data. The primary review outcome was live birth rate. The secondary outcomes were clinical pregnancy rate, oocytes retrieved, embryo transfer, units of gonadotropin used and adverse events, i.e. ectopic pregnancy, multiple pregnancy, ovarian hyperstimulation syndrome (OHSS), congenital anomalies, oedema. </p> </section> <section id="CD000099-sec-0006"> <h3 class="title" id="CD000099-sec-0006">Main results</h3> <p>We included 16 RCTs (1352 women). Two RCTs (80 women) studied GH in routine use, and 14 RCTs (1272 women) studied GH in poor responders. The evidence was low to very low certainty, the main limitations being risk of bias, imprecision and heterogeneity. </p> <p><b>Adjuvant growth hormone compared to no adjuvant: routine use for in vitro fertilisation (IVF)</b> </p> <p>The evidence is very uncertain about the effect of GH on live birth rate per woman randomised for routine use in IVF (odds ratio (OR) 1.32, 95% confidence interval (CI) 0.40 to 4.43; I<sup>2</sup> = 0%; 2 trials, 80 participants; very low‐certainty evidence). If the chance of live birth without adjuvant GH is assumed to be 15%, the chance of live birth with GH would be between 6% and 43%. </p> <p>There was insufficient evidence to reach a conclusion regarding clinical pregnancy rates per woman randomised, number of women with at least one oocyte retrieved per woman randomised and embryo transfer achieved per woman randomised; reported data were unsuitable for analysis. </p> <p>The evidence is very uncertain about the effect of GH on mean number of oocytes retrieved in normal responders (mean difference (MD) ‐0.02, 95% CI ‐0.79 to 0.74; I<sup>2</sup> = 0%; 2 trials, 80 participants; very low‐certainty evidence). </p> <p>The evidence is very uncertain about the effect of GH on mean units of gonadotropin used in normal responders (MD 13.57, 95% CI ‐112.88 to 140.01; I<sup>2</sup> = 0%; 2 trials, 80 participants; very low‐certainty evidence). </p> <p>We are uncertain of the effect of GH on adverse events in normal responders.</p> <p><b>Adjuvant growth hormone compared to no adjuvant: use in poor responders for in vitro fertilisation (IVF)</b> </p> <p>The evidence is very uncertain about the effect of GH on live birth rate per woman randomised for poor responders (OR 1.77, 95% CI 1.17 to 2.70; I<sup>2</sup> = 0%; 8 trials, 737 participants; very low‐certainty evidence). If the chance of live birth without adjuvant GH is assumed to be 11%, the chance of live birth with GH would be between 13% and 25%. Adjuvant GH results in a slight increase in pregnancy rates in poor responders (OR 1.85, 95% CI 1.35 to 2.53; I<sup>2</sup> = 15%; 11 trials, 1033 participants; low‐certainty evidence). The results suggest, if the pregnancy rate without adjuvant GH is assumed to be 15%, with GH the pregnancy rate in poor responders would be between 19% and 31%. The evidence suggests that GH results in little to no difference in number of women with at least one oocyte retrieved (OR 5.67, 95% CI 1.54 to 20.83; I<sup>2</sup> = 0%; 2 trials, 148 participants; low‐certainty evidence). If the chance of retrieving at least one oocyte in poor responders was 81%, with GH the chance is between 87% and 99%. There is a slight increase in mean number of oocytes retrieved with the use of GH for poor responders (MD 1.40, 95% CI 1.16 to 1.64; I<sup>2</sup> = 87%; 12 trials, 1153 participants; low‐certainty evidence). The evidence is very uncertain about the effect of GH on embryo transfer achieved (OR 2.32, 95% CI 1.08 to 4.96; I<sup>2</sup> = 25%; 4 trials, 214 participants; very low‐certainty evidence). If the chance of achieving embryo transfer is assumed to be 77%, the chance with GH will be 78% to 94%. Use of GH results in reduction of mean units of gonadotropins used for stimulation in poor responders (MD ‐1088.19, 95% CI ‐1203.20 to ‐973.18; I<sup>2</sup> = 91%; 8 trials, 685 participants; low‐certainty evidence). </p> <p>High heterogeneity in the analyses for mean number of oocytes retrieved and units of GH used suggests quite different effects according to differences including in trial protocols (populations, GH dose and schedule), so these results should be interpreted with caution. </p> <p>We are uncertain of the effect of GH on adverse events in poor responders as six of the 14 included trials failed to report this outcome. </p> </section> <section id="CD000099-sec-0007"> <h3 class="title" id="CD000099-sec-0007">Authors' conclusions</h3> <p>The use of adjuvant GH in IVF treatment protocols has uncertain effect on live birth rates and mean number of oocytes retrieved in normal responders. However, it slightly increases the number of oocytes retrieved and pregnancy rates in poor responders, while there is an uncertain effect on live birth rates in this group. The results however, need to be interpreted with caution, as the included trials were small and few in number, with significant bias and imprecision. Also, the dose and regimen of GH used in trials was variable. Therefore, further research is necessary to fully define the role of GH as adjuvant therapy in IVF. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD000099-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000099-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000099-abs-0019">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000099-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000099-abs-0016">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD000099-abs-0012">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/hu#CD000099-abs-0017">Magyar</a> </li> <li class="section-language"> <a class="" href="full/ja#CD000099-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD000099-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD000099-abs-0009">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD000099-abs-0007">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000099-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD000099-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD000099-abs-0002" lang="en"> <h3>Growth hormone for in vitro fertilisation (IVF)</h3> <p><b>Review question</b> </p> <p>Cochrane researchers reviewed the evidence about giving growth hormone as an additional treatment to women undergoing IVF compared to not giving this treatment to such women. </p> <p><b>Background</b> </p> <p>During an IVF cycle, women need to be given gonadotrophin therapy to stimulate ovaries to produce eggs. Theoretically, the use of growth hormone as an added treatment may enhance the response of gonadotrophin therapy. We assessed the benefits and risks of using growth hormone compared with no growth hormone treatment in women undergoing IVF. 'Poor responders' in IVF treatment are usually older women with low ovarian reserve or women who had previous IVF treatment with less than five eggs collected despite a maximum dose of stimulation medication. Younger women with good ovarian reserve and good ovarian response (&gt; 5 eggs collected) after ovarian stimulation are considered normal responders. </p> <p><b>Study characteristics</b> </p> <p>We found 16 randomised controlled trials with 1352 women. This type of trial randomly assigns people into two groups. In this case, one group received IVF plus growth hormone and the other group received IVF only. The evidence is current to 11 November 2020. </p> <p><b>Key results</b> </p> <p>In normal responders, with adjuvant GH use, the effect on live birth rate is very uncertain; if the chance of live birth without growth hormone is assumed to be 15%, the chance of live birth with growth hormone would be between 6% and 43%. There was not enough evidence to reach a conclusion regarding clinical pregnancy rates, number of women with at least one egg retrieved, embryo transfer achieved, and number of eggs retrieved in normal responders. The evidence is also very uncertain about the effect of growth hormone on mean units of gonadotropin used in normal responders. </p> <p>The evidence is very uncertain about the effect of growth hormone on live birth rate for poor responders, based on eight trials. If the chance of live birth without growth hormone is assumed to be 11%, the chance of live birth with growth hormone would be between 13% and 25%. Growth hormone results in a slight increase in pregnancy rates in poor responders, based on 11 trials with low‐certainty evidence. The results suggest, if the pregnancy rate without growth hormone is assumed to be 15%, with growth hormone use, the pregnancy rate in poor responders would be between 19% and 31%. The evidence suggests that growth hormone results in little to no difference in the number of women with at least one oocyte retrieved, based on two trials with low‐certainty evidence. If the chance of retrieving at least 1 egg in poor responders was 81%, with growth hormone the chance is between 87% and 99%. There is a slight increase in the mean number of oocytes retrieved with the use of growth hormone for poor responders, based on 12 trials with low‐certainty evidence. The evidence is very uncertain about the effect of growth hormone on embryo transfer achieved, based on four trials. If the chance of achieving embryo transfer is assumed to be 77%, the chance with use of growth hormone will be between 78% and 94%. Use of growth hormone results in reduction of mean units of gonadotropins used for stimulation in poor responders, based on eight trials with low‐certainty evidence. </p> <p>High heterogeneity in the analyses for the mean number of oocytes retrieved and the mean units of GH used suggests quite different effects according to differences including in trial protocols (populations, GH dose and schedule), so these results should be interpreted with caution. </p> <p>We are uncertain of the effect of growth hormone on adverse events in normal or poor responders as 6 of the 16 included trials failed to report this outcome. </p> <p><b>Quality of the evidence</b> </p> <p>The evidence was of low to very low certainty, with the main limitations being poor reporting of study methods, imprecise data and variability among the trials. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD000099-sec-0096" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD000099-sec-0096"></div> <h3 class="title" id="CD000099-sec-0097">Implications for practice</h3> <section id="CD000099-sec-0097"> <p>Use of adjuvant GH in IVF treatment protocols slightly increases the number of oocytes retrieved and pregnancy rates in 'poor responders' but has uncertain effects on live birth rates. The results however, need to be interpreted with caution, as the included trials were small and few in number, with significant bias and imprecision. Also, the dose and regimen of GH used in trials was variable. Therefore, further research is necessary to fully define the role of GH as adjuvant therapy in IVF. Furthermore, the cost of the intervention has been reported by only one study (<a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>), which was nearly double the cost without adjuvant GH use. This could affect the applicability of GH in practice, as the cost of IVF treatment with GH will be significantly higher than without, making treatment with GH unaffordable for some women. </p> </section> <h3 class="title" id="CD000099-sec-0098">Implications for research</h3> <section id="CD000099-sec-0098"> <p>With regards to women who are known poor responders to IVF, a multiple‐centre randomised double‐blinded trial is warranted to investigate the effect of GH augmentation. Key elements of design should include a power calculation to ensure the minimum number of participants needed for a significant result are included, the standardisation of controlled ovarian hyperstimulation protocols, and dose of GH and subgroups based on POSEIDON criteria (<a href="./references#CD000099-bbs2-0087" title="HumaidanP , AlviggiC , FischerR , EstevesSC . The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome. F1000 Research2016;5:2911. [DOI: doi:10.12688/f1000research.10382.1]">POSEIDON criteria 2016</a>). The primary outcome of live birth rate should be measured. Only by considering such outcomes can this therapy be truly tested. Also, adverse events should be routinely reported. Given the high cost of GH treatment, one component of new trials should also be an economic evaluation. Newer avenues of research include the potential role of GH in improving uterine receptivity and improved outcomes in women with recurrent implantation failure. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD000099-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD000099-sec-0008"></div> <div class="table" id="CD000099-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Adjuvant growth hormone compared to no adjuvant: routine use for in vitro fertilisation (IVF)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Adjuvant growth hormone compared to no adjuvant: routine use for in vitro fertilisation (IVF)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with infertility <br/><b>Setting:</b> IVF<br/><b>Intervention:</b> growth hormone <br/><b>Comparison:</b> no adjuvant </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants(trials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with no adjuvant: routine use</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with growth hormone</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Live birth rate per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.32<br/>(0.40 to 4.43) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>80<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of growth hormone on live birth rate per woman randomised in normal responders </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 100<br/>(6 to 43) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical pregnancy rate per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.78<br/>(0.49 to 6.50) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>42<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Only one study reported this outcome, hence conclusions cannot be drawn.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>27 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 100<br/>(16 to 71) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of women with at least one oocyte retrieved per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.86<br/>(0.11 to 74.31) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>42<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Only one study reported this outcome, hence conclusions cannot be drawn.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>95 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>98 per 100<br/>(70 to 100) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean number of oocytes retrieved</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of oocytes retrieved ranged from 6 to 13</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.02 lower<br/>(0.79 lower to 0.74 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of growth hormone on mean number of oocytes retrieved in normal responders. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Embryo transfer achieved per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 7.36<br/>(0.36 to 151.91) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>42<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Only one study reported this outcome, hence conclusions cannot be drawn.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>86 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>98 per 100<br/>(70 to 100) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean units of gonadotrophin used</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean units of gonadotrophin used ranged from 1327 to 2820 units</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 13.57 units higher<br/>(112.88 lower to 140.01 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of growth hormone on mean units of gonadotrophin used in normal responders. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a> reported: </p> <p>‐ ectopic pregnancy 0/20 in GH group and 2/22 in control group</p> <p>‐ multiple pregnancy 5/20 in GH group and 2/22 in control group</p> <p>‐ OHSS 0/20 in GH group and 0/22 in control group</p> <p><a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a> reported: </p> <p>‐ multiple pregnancy 0/19 in GH group and 1/19 in control group. Other adverse events were not reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>e,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that growth hormone does not increase or reduce adverse events in normal responders. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/><b>CI:</b> confidence interval; <b>GH</b> : growth hormone; <b>IVF</b> : in vitro fertilisation; <b>MD</b> : mean difference; <b>OR:</b> odds ratio; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to randomisation bias and selective reporting. There are only 2 trials in this analysis.<br/><sup>b</sup>Downgraded 2 levels due to imprecision, small study numbers and very wide confidence intervals.<br/><sup>c</sup>Downgraded one level due to randomisation bias and selective reporting.<br/><sup>d</sup>Only one study reported this outcome, hence downgraded.<br/><sup>e</sup>Not all outcomes reported uniformly.<br/><sup>f</sup>Small study numbers. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000099-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Adjuvant growth hormone compared to no adjuvant: poor responders for in vitro fertilisation (IVF)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Growth hormone compared to no adjuvant: poor responders for in vitro fertilisation (IVF)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with infertility subclassified as poor responders<br/><b>Setting:</b> IVF <br/><b>Intervention:</b> growth hormone <br/><b>Comparison:</b> no adjuvant </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(trials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with no adjuvant: poor responders</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with growth hormone</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Live birth rate per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.77<br/>(1.17 to 2.70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>737<br/>(8 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of growth hormone on live birth rate per woman randomised in poor responders. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 100<br/>(13 to 25) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical pregnancy rate per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.85<br/>(1.35 to 2.53) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1033<br/>(11 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Growth hormone may result in a slight increase in clinical pregnancy rate per woman randomised in poor responders. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>25 per 100<br/>(19 to 31) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of women with at least one oocyte retrieved per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 5.67<br/>(1.54 to 20.83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>148<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence suggests that growth hormone results in little to no difference in number of women with at least one oocyte retrieved per woman randomised. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>81 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>96 per 100<br/>(87 to 99) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean number of oocytes retrieved</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of oocytes retrieved ranged from 2 to 6</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1.40 higher<br/>(1.16 higher to 1.64 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1153<br/>(12 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Growth hormone may result in a slight increase in mean number of oocytes retrieved in poor responders. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Embryo transfer achieved per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.32<br/>(1.08 to 4.96) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>214<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of growth hormone on embryo transfer achieved per woman randomised in poor responders. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>77 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>89 per 100<br/>(78 to 94) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean units gonadotropin used</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean units gonadotropin used ranged from 2548 to 5590 units</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1088.19 units lower<br/>(1203.2 lower to 973.18 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>685<br/>(8 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests growth hormone results in a slight reduction in mean units of gonadotropin used in poor responders. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Six trials did not report adverse events (<a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a>; <a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>; <a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>). The other 8 trials reported adverse events. <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a> reported ectopic pregnancies: 0/13 in GH group and 1/12 in control; the other trials in poor responder group reported no cases of ectopic pregnancy in either group. Multiple pregnancy was reported in <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>: 2/13 in GH group and 0/12 in control group; <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a> reported 1/78 in GH group and 1/78 in control group; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a> reported 1/10 in 4 IU GH group and 0/6 in control group; and other trials reported no cases of multiple pregnancies in either group. <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a> reported congenital anomalies: 1/65 in GH group and 1/65 in control group; other trials reported no cases of congenital anomalies in either group. <a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a> reported that 2/29 cases in GH group had oedema, but this outcome was not reported by any other study. <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>, <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a> and <a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a> reported that no adverse events were seen in either group. This information has been presented in tabular form (<a href="./full#CD000099-tbl-0003">Table 1</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>512<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>e,g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Results reported varied across the studies, from an increase to a decrease of AEs with use of GH, but the evidence is very uncertain. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/><b>CI:</b> confidence interval; <b>IVF</b> : in vitro fertilisation; <b>MD</b> : mean difference; <b>OR:</b> odds ratio; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of attrition bias.<br/><sup>b</sup>Downgraded one level due to imprecision, small numbers and wide confidence intervals.<br/><sup>c</sup>Downgraded one level due to publication bias as per funnel plot.<br/><sup>d</sup>Downgraded one level due to randomisation bias and selective reporting.<br/><sup>e</sup>The dose, form, timing of administration was inconsistent across various trials.<br/><sup>f</sup>Downgraded one level due to allocation bias and selective reporting.<br/><sup>g</sup>Adverse events have not been reported by all trials, and the ones reporting have not reported adverse events long term. In particular effects on developing foetus have only been reported by one study. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000099-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">1.</span> <span class="table-title">Adverse events</span></div> <tbody> <tr> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Trial</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Response type</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>AE reported</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Ectopic</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Multiple</b> <br/><b>pregnancy</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Congenital</b> <br/><b>anomalies</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>OHSS</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Oedema</b> </p> </th> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GH</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GH</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GH</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GH</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GH</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>2/29</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>1/78</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>1/78</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>1/65</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>1/65</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0/13</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>1/12</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>2/13</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0/12</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>1/10<br/>(4IU group) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/6</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Normal</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>1/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Normal</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0/20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>2/22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>5/20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>2/22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0/20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0/22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> </tbody> <tfoot> <tr> <td colspan="13"> <div class="table-footnote"> <p> <ul id="CD000099-list-0001"> <li> <p>IU: international units</p> </li> <li> <p>AE: adverse effects</p> </li> <li> <p>OHSS: ovarian hyperstimulation syndrome</p> </li> </ul> </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD000099-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD000099-sec-0009"></div> <section id="CD000099-sec-0010"> <h3 class="title" id="CD000099-sec-0010">Description of the condition</h3> <p>Infertility, usually defined as absence of conception after one year of regular intercourse, is a common problem affecting as many as one in six couples(<a href="./references#CD000099-bbs2-0085" title="Fertility: Assessment and Treatment for People with Fertility Problems. National Collaborating Centre for Women’s and Children’s Health (UK). Feb 2013. [PMID: 25340218]">NICE CG156</a>). The main causes include sperm dysfunction, ovulation disorder and fallopian tube damage (<a href="./references#CD000099-bbs2-0067" title="CahillD , WardlePG . Management of Infertility. BMJ2002;325(7354):28-32.">Cahill 2002</a>). Even after undergoing diagnostic tests, approximately 30% cases of infertility remain unexplained. One method of treating infertile couples is assisted conception via in vitro fertilisation (IVF). IVF involves using hormones to stimulate ovaries in order to increase follicular growth and thus develop more than one oocyte. Ovulation is then triggered with human chorionic gonadotropin and the oocytes are retrieved and fertilised with sperm in the laboratory setting outside the body (in vitro) (<a href="./references#CD000099-bbs2-0065" title="Bhandari, HM, Choudhary, MK, Stewart, JA. An overview of assisted reproductive technology procedures.. The Obstetrician &amp;Gynaecologist. 2018;20:167–176.2018;20:167-176. [DOI: https://doi.org/10.1111/tog.12509]">Bhandari 2018</a>). The fertilised oocytes (embryos) are then transferred into the uterus, two to five days after egg retrieval. IVF protocols are constantly under review in an attempt to decrease hormone (gonadotrophin) requirement, improve follicular recruitment, and ultimately increase live birth rates (<a href="./references#CD000099-bbs2-0065" title="Bhandari, HM, Choudhary, MK, Stewart, JA. An overview of assisted reproductive technology procedures.. The Obstetrician &amp;Gynaecologist. 2018;20:167–176.2018;20:167-176. [DOI: https://doi.org/10.1111/tog.12509]">Bhandari 2018</a>). A challenge for IVF practitioners is to optimise the outcome in 'poor responders'. As per the consensus from the European Society of Human Reproduction and Embryology (ESHRE), poor ovarian response has been defined if at least two of the following three features are present: i) increased maternal age (&gt; 40 years); ii) any other risk factor for poor ovarian response (3 or fewer oocytes with ovulation induction); and iii) low scores on tests of ovarian reserve (i.e. antral follicle count &lt; 5 to 7 follicles or anti‐Müllerian hormone &lt; 0.5 ng/mL to 1.1 ng/mL (<a href="./references#CD000099-bbs2-0073" title="FerrarettiAP , La MarcaA , FauserBC , TarlatzisB , NargundG , GianaroliL , ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human Reproduction2011;26(7):1616-24.">Ferraratti 2011</a>). A newer classification system has been proposed by the POSEIDON group (<b>P</b> atient‐<b>O</b> riented <b>S</b> trategies <b>E</b> ncompassing <b>I</b> ndividualize<b>D O</b> ocyte <b>N</b>umber; <a href="./references#CD000099-bbs2-0088" title="AlviggiC , AndersenCY , BuehlerK , ConfortiA , De PlacidoG , EstevesSC , et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Ferility and Sterility2016;105(6):1452-3. [DOI: doi: 10.1016/j.fertnstert.2016.02.005.] [PMID: Epub 2016 Feb 26. PMID: 26921622.]">POSEIDON Group 2016</a>). In this classification, four subgroups have been suggested based on quantitative and qualitative parameters, namely, age and the expected aneuploidy rate; ovarian biomarkers (i.e. antral follicle count and anti‐Müllerian hormone); and ovarian response ‐ provided a previous stimulation cycle was performed (<a href="./references#CD000099-bbs2-0087" title="HumaidanP , AlviggiC , FischerR , EstevesSC . The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome. F1000 Research2016;5:2911. [DOI: doi:10.12688/f1000research.10382.1]">POSEIDON criteria 2016</a>). The POSEIDON group also introduced a new measure for successful assisted reproductive technology treatment, namely, the ability to retrieve the number of oocytes needed for the patient to obtain at least one euploid embryo for transfer. This feature represents a pragmatic endpoint for clinicians and enables the development of prediction models aiming to reduce the time‐to‐pregnancy. This however, can only be applied to prospective RCTs, and has not been used by any of the trials included in this meta‐analysis. </p> </section> <section id="CD000099-sec-0011"> <h3 class="title" id="CD000099-sec-0011">Description of the intervention</h3> <p>Over the last 25 years growth hormone (GH) has been used in IVF treatment (<a href="./references#CD000099-bbs2-0035" title="JacobsHS , ShohamZ , SchachterM , BraatDD , FranksS , Hamilton-FairleyD . Cotreatment with growth hormone and gonadotropin for ovulation induction in hypogonadotropic patients: A prospective, randomized, placebo-controlled, dose-response study. Fertility and Sterility1995;64(5):917-23. ">Jacobs 1995</a>; <a href="./references#CD000099-bbs2-0036" title="LandolfiL , MarraV , GallinaN . Ovulation induction with growth hormone and GnRH in polycystic ovarian disease. Rassegna Internazionale di Clinica e Terapia1994;74(12):529-32. ">Landolfi 1994</a>). GH is a biological peptide hormone, synthesised, stored and secreted by somatotroph cells located in the anterior pituitary gland (<a href="./references#CD000099-bbs2-0044" title="ReganSLP , KnightPG , YovichJL , ArfusoF , DharmarajanA . Growth hormone during in vitro fertilization in older women modulates the density of receptors in granulosa cells, with improved pregnancy outcomes. Fertility and Sterility Dec 2018;110(7):1298-1309. ">Regan 2018</a>). GH can be synthetically produced using recombinant DNA technology and is licensed to be used in the human population. There is currently no consensus as to the route, dose or timing of GH administration in IVF protocols (<a href="./references#CD000099-bbs2-0094" title="AhmadG , BrownJ , DuffyJM , NardoLG , WatsonA . Growth hormone for in vitro fertilization. Cochrane Database of Systematic Reviews2009, Issue 4. Art. No: CD000099. [DOI: 10.1002/14651858.CD000099.pub2]">Ahmad 2009</a>) </p> </section> <section id="CD000099-sec-0012"> <h3 class="title" id="CD000099-sec-0012">How the intervention might work</h3> <p>The administration of GH may potentiate the effect of exogenous gonadotrophins (<a href="./references#CD000099-bbs2-0079" title="HomburgR , EshelA , AbdullaHI , JacobsHS . Growth hormone facilitates ovulation induction by gonadotrophins. Clinical Endocrinology1988;29:113-8.">Homburg 1988</a>; <a href="./references#CD000099-bbs2-0093" title="ZhouP , BaumgartenSC , WuY . IGF-I signalling is essential for FSH stimulation of AKT and steroidogenic genes in granulosa cells.. Molecular Endocrinology2013;27:511-23.">Zhou 2013</a>). GH is reported to modulate the action of follicular stimulating hormones on granulosa cells by up‐regulating the local synthesis of insulin‐like growth factor‐1 (IGF‐1) (<a href="./references#CD000099-bbs2-0044" title="ReganSLP , KnightPG , YovichJL , ArfusoF , DharmarajanA . Growth hormone during in vitro fertilization in older women modulates the density of receptors in granulosa cells, with improved pregnancy outcomes. Fertility and Sterility Dec 2018;110(7):1298-1309. ">Regan 2018</a>). This interest has been stimulated by animal trials which suggest that GH may increase the intraovarian production of IGF‐1 (<a href="./references#CD000099-bbs2-0081" title="HsuDJ , HammondJM . Concomitant effects of growth hormone on secretion of insulin-like growth factor I and progesterone by cultured porcine granulosa cells. Endocrinology1987;121(4):1343-8.">Hsu 1987</a>; <a href="./references#CD000099-bbs2-0092" title="YoshimuraY , AndoM , NagamatsuS , IwashitaM , AdachiT , SueokaK . Effects of insulin-like growth factor-I on follicle growth, oocyte maturation, and ovarian steroidogenesis and plasminogen activator activity in the rabbit. Biology of Reproduction1996;55(1):152-60.">Yoshimura 1996</a>). IGF‐1 displays GH dependence both in vivo and in vitro (<a href="./references#CD000099-bbs2-0066" title="BlumenfeldZ , AmitT . The role of growth hormone (GH), GH-receptor and GH-binding protein in reproduction and ovulation induction. Journal of Pediatric Endocrinology &amp; Metabolism1996;9:145-62.">Blumenfeld 1996</a>). The interaction between GH and IGF‐1 is of significance since IGF‐1 has been shown to play an important part in ovarian function in both animal and human models (<a href="./references#CD000099-bbs2-0063" title="AdashiEY , ResnickCE , D'ErcoleAJ , SvobodaME , Van WykeJ . Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocrinology Review1985;6:400-20.">Adashi 1985</a>; <a href="./references#CD000099-bbs2-0072" title="EricksonGF , GabrielVG , MagoffinDA . Insulin-like factor-I regulates aromatase activity in human granulosa and granulosa luteal cells. Journal of Clinical Endocrinological Metabolism1989;69:716-24.">Erickson 1989</a>; <a href="./references#CD000099-bbs2-0093" title="ZhouP , BaumgartenSC , WuY . IGF-I signalling is essential for FSH stimulation of AKT and steroidogenic genes in granulosa cells.. Molecular Endocrinology2013;27:511-23.">Zhou 2013</a>). The addition of IGF‐1 to gonadotrophins in granulosa cell cultures increased gonadotrophin action on the ovary by several mechanisms including augmentation of aromatase activity, 17 beta‐oestradiol and progesterone production and luteinising hormone receptor formation (<a href="./references#CD000099-bbs2-0072" title="EricksonGF , GabrielVG , MagoffinDA . Insulin-like factor-I regulates aromatase activity in human granulosa and granulosa luteal cells. Journal of Clinical Endocrinological Metabolism1989;69:716-24.">Erickson 1989</a>; <a href="./references#CD000099-bbs2-0084" title="MasonHD , MartikainenH , BeardRW , AnyaokuV , FranksS . Direct gonadotrophic effect of growth hormone on oestradiol production by human granulosa cell in vitro. Journal of Endocrinology1990;126:R1-R2.">Mason 1990</a>). In human ovarian cells, IGF‐1, in synergy with FSH (follicle stimulating hormone), stimulates protein synthesis and steroidogenesis. Following the presence of luteinising hormone receptors, IGF‐1 enhances luteinising hormone‐induced progesterone synthesis and stimulates proliferation of granulosa‐luteal cells. IGF‐1, in synergy with FSH, is very influential in stimulating aromatase activity in preovulatory follicles. Thus, IGF‐1 can be involved in both estradiol and progesterone synthesis (<a href="./references#CD000099-bbs2-0093" title="ZhouP , BaumgartenSC , WuY . IGF-I signalling is essential for FSH stimulation of AKT and steroidogenic genes in granulosa cells.. Molecular Endocrinology2013;27:511-23.">Zhou 2013</a>). In other words, the existence of GH is essential in follicle development and ovarian steroidogenesis. IGF‐1 has also been found to stimulate follicular development, oestrogen production and oocyte maturation (<a href="./references#CD000099-bbs2-0044" title="ReganSLP , KnightPG , YovichJL , ArfusoF , DharmarajanA . Growth hormone during in vitro fertilization in older women modulates the density of receptors in granulosa cells, with improved pregnancy outcomes. Fertility and Sterility Dec 2018;110(7):1298-1309. ">Regan 2018</a>; <a href="./references#CD000099-bbs2-0092" title="YoshimuraY , AndoM , NagamatsuS , IwashitaM , AdachiT , SueokaK . Effects of insulin-like growth factor-I on follicle growth, oocyte maturation, and ovarian steroidogenesis and plasminogen activator activity in the rabbit. Biology of Reproduction1996;55(1):152-60.">Yoshimura 1996</a>). Trials have shown that maturation and evolution of oocytes have been impaired or severely reduced by inhibiting the GH receptor in animal models (<a href="./references#CD000099-bbs2-0083" title="LucyMC . Growth hormone regulation of follicular growth. Reproduction, Fertility and Development2011;24:19-28.">Lucy 2011</a>). GH is an essential requirement in treatment of infertility for women with GH deficiency, with many such women presenting with ovulation disorder (<a href="./references#CD000099-bbs2-0086" title="ParkJK , MurphyAA , BordeauxBL , DominguezCE , SessionDR . Ovulation induction in a poor responder with panhypopituitarism: a case report and review of the literature. Gynecological Endocrinology2007;23:82-6.">Park 2007</a>). </p> </section> <section id="CD000099-sec-0013"> <h3 class="title" id="CD000099-sec-0013">Why it is important to do this review</h3> <p>The aim of this review is to establish the role of GH in IVF. Improving the outcomes of IVF with the use of GH adjuvant therapy is important particularly in those women who are considered poor responders. Since GH treatment is expensive, it is important to examine the available evidence as to the effectiveness and safety of its use as an adjunct to IVF, as its routine use could render IVF treatment unaffordable for many more patients, than is the case now (<a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD000099-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD000099-sec-0014"></div> <p>To assess the effectiveness and safety of growth hormone as an adjunct to IVF compared to standard IVF for women with infertility </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD000099-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD000099-sec-0015"></div> <section id="CD000099-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD000099-sec-0017"> <h4 class="title">Types of studies</h4> <p>Only randomised controlled trials (RCTs) were eligible for inclusion.</p> </section> <section id="CD000099-sec-0018"> <h4 class="title">Types of participants</h4> <p>Women with infertility undergoing ovarian stimulation for IVF</p> </section> <section id="CD000099-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included all RCTs comparing the use of adjuvant GH in IVF cycles with standard IVF cycles, with or without placebo control. </p> </section> <section id="CD000099-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD000099-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD000099-list-0002"> <li> <p>Live birth rate per woman randomised: number of women achieving a live birth divided by the number of women randomised </p> </li> </ul> </p> </section> <section id="CD000099-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD000099-list-0003"> <li> <p>Cinical pregnancy rate per woman randomised: number of women achieving a clinical pregnancy (established with confirmation of ongoing intrauterine pregnancy at 6 weeks on ultrasound), divided by the number of women randomised </p> </li> <li> <p>Oocyte retrieval per woman randomised: number of women with at least one oocyte retrieved divided by the number of women randomised </p> </li> <li> <p>Mean number of oocytes retrieved</p> </li> <li> <p>Embryo transfer per woman randomised: number of women with at least one embryo transferred divided by the number of women randomised </p> </li> <li> <p>Mean units of gonadotrophin used</p> </li> <li> <p>Adverse events (ectopic pregnancy, multiple pregnancy, ovarian hyperstimulation syndrome (OHSS), congenital anomalies, oedema). </p> </li> </ul> </p> </section> </section> </section> <section id="CD000099-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD000099-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We searched the following electronic databases for relevant trials to 11 November 2020: </p> <p> <ul id="CD000099-list-0004"> <li> <p>The Cochrane Gynaecology and Fertility (CGF) Group Specialised Register of Controlled Trials, ProCite platform (searched 11 November 2020) (<a href="./appendices#CD000099-sec-0102">Appendix 1</a>); </p> </li> <li> <p>CENTRAL, via the Cochrane Register of Studies Online (CRSO); Web platform (searched 11 November 2020) (<a href="./appendices#CD000099-sec-0103">Appendix 2</a>); </p> </li> <li> <p>MEDLINE, Ovid platform (searched from 1946 to 11 November 2020) (<a href="./appendices#CD000099-sec-0104">Appendix 3</a>); </p> </li> <li> <p>Embase, Ovid platform (searched from 1980 to 11 November 2020) (<a href="./appendices#CD000099-sec-0105">Appendix 4</a>); </p> </li> <li> <p>PsycINFO, Ovid platform (searched from 1806 to 11 November 2020) (<a href="./appendices#CD000099-sec-0106">Appendix 5</a>); </p> </li> <li> <p>CINAHL Plus, Ebsco platform (searched from 1961 to 20 January 2020 and any later CINAHL search output from the 11 November 2020 search is contained in the CENTRAL output) (<a href="./appendices#CD000099-sec-0107">Appendix 6</a>). </p> </li> </ul> </p> <p>The MEDLINE search was combined with the Cochrane highly sensitive search strategy for identifying randomised trials which appears in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Version 5.1.0 chapter 6, 6.4.11)(<a href="./references#CD000099-bbs2-0078" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>). We combined the Embase searches with trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN) (<a href="https://www.sign.ac.uk/what-we-do/methodology/search-filters/" target="_blank">www.sign.ac.uk/what-we-do/methodology/search-filters/</a>) </p> <p>Other electronic sources of trials include:</p> <p> <ul id="CD000099-list-0005"> <li> <p>LILACS (Latin American and Caribbean Health Science Information database (searched from 1982 to 11 November 2020), found in the Virtual Health Library Regional Portal (VHL) (<a href="https://pesquisa.bvsalud.org/portal/" target="_blank">pesquisa.bvsalud.org/portal</a>); </p> </li> <li> <p>Google Scholar (for recent trials not yet indexed in the major databases).</p> </li> </ul> </p> </section> <section id="CD000099-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We handsearched the reference lists of articles retrieved by the search and made personal contact with experts in the field and with the manufacturers of GH to obtain any additional relevant trials. In liaison with the Information Specialist, we handsearched any relevant journals and conference abstracts that were not covered in the CGF register. </p> <p>We also rescreened the trials included in the previous version of this review.</p> </section> </section> <section id="CD000099-sec-0026"> <h3 class="title" id="CD000099-sec-0026">Data collection and analysis</h3> <section id="CD000099-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two review authors (AS and GM) scanned retrieved searches for relevant titles and abstracts and retrieved the full text of all potentially eligible trials. The same review authors independently examined the full text articles for compliance with the inclusion criteria and elected trials eligible for inclusion in the review. We corresponded with study investigators to clarify study eligibility (for example, with respect to participant eligibility criteria and allocation method). Disagreements as to study eligibility were resolved by discussion with a third review author (LM). We used a PRISMA flow chart to explain this process (<a href="./references#CD000099-bbs2-0089" title="PageMJ , McKenzieJE , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.. Systematic Reviews2021;10:89.">PRISMA 2021</a>) </p> </section> <section id="CD000099-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (GM and AS) independently extracted data from eligible trials using a data extraction form designed and pilot tested by review authors. Any disagreements were resolved by a third review author (LM). Where trials have multiple publications, we used the main trial report as the reference and supplemented this with additional details from secondary papers. Review authors corresponded with study investigators in order to resolve data queries. </p> </section> <section id="CD000099-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (GM and AS) assessed the included trials for risk of bias using the Cochrane RoB 1 tool (<a href="./references#CD000099-bbs2-0077" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>); any disagreements were resolved by discussion with a third review author (LM). We assessed: sequence generation; allocation concealment; blinding of participants, providers and outcome assessors; completeness of outcome data; selective outcome reporting; and other potential sources of bias (<a href="./references#CD000099-bbs2-0077" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). The conclusions are presented in the risk of bias table and incorporated in the interpretation of review findings by means of sensitivity analyses (see below). Where identified trials failed to report the primary outcomes of live birth, but did report secondary outcomes such as clinical pregnancy, we undertook informal assessment as to whether those reporting the primary outcomes have typical values of the secondary outcomes. </p> </section> <section id="CD000099-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous data (e.g. live birth rates), we used the numbers of events in the control and intervention groups of each study to calculate Mantel‐Haenszel odds ratios (ORs) or (where events are very rare) Peto ORs*. For continuous data (e.g. weight gain), if all trials report exactly the same outcomes, we calculated the mean difference (MD) between treatment groups. If similar outcomes are reported on different scales (e.g. change in weight) we calculated the standardised mean difference (SMD). We reversed the direction of effect of individual trials, if required, to ensure consistency across trials. We treated ordinal data (e.g. quality of life scores) as continuous data. We presented 95% confidence intervals (CIs) for all outcomes. Where data to calculate ORs or MDs were not available, we utilised the most detailed numerical data available that facilitated similar analyses of included trials (e.g. test statistics, P values). We assessed whether the estimates calculated in the review for individual trials are compatible in each case with the estimates reported in the study publications. Three trails reported data as median and range (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>). We converted the data to mean and standard deviation (SD) using Hozo's method (<a href="./references#CD000099-bbs2-0080" title="HozoSP , DjulbegovicB , HozoI . Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology2005;5:13. [DOI: https://doi.org/10.1186/1471-2288-5-13]">Hozo 2005</a>). </p> </section> <section id="CD000099-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>The primary analysis was per woman randomised. Multiple live births (e.g. twins or triplets) were to be counted as one live birth event. </p> </section> <section id="CD000099-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We analysed the data on an intention‐to‐treat basis as far as possible and made attempts to obtain missing data from the original investigators. If trials reported sufficient detail to calculate MDs but no information on associated SD, we planned to assume that the outcome had a SD equal to the highest SD from other trials within the same analysis. We assumed live births and pregnancies not to have occurred in participants with unreported outcomes. Where these were unobtainable, imputation of individual values was undertaken for the primary outcomes only. For other outcomes, we only analysed the available data. Any imputation undertaken was subjected to sensitivity analysis (see below). </p> </section> <section id="CD000099-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We considered whether the clinical and methodological characteristics of the included trials were sufficiently similar for meta‐analysis to provide a meaningful summary. We assessed statistical heterogeneity using the I<sup>2</sup> statistic. An I<sup>2</sup> measurement greater than 50% indicated substantial heterogeneity (<a href="./references#CD000099-bbs2-0077" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>), and if present, we addressed this through sensitivity analysis, subgroup analysis, or both. </p> </section> <section id="CD000099-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>In view of the difficulty in detecting and correcting for publication bias and other reporting biases, we aimed to minimise their potential impact by ensuring a comprehensive search for eligible trials, by being alert for duplication of data, and by constructing a funnel plot if there were sufficient trials (10 or more) in one analysis. </p> </section> <section id="CD000099-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We combined the data from primary trials using fixed‐effect models in the following comparisons. </p> <p> <ul id="CD000099-list-0006"> <li> <p>GH versus no adjuvant treatment: routine use of adjuvant GH in IVF protocols</p> </li> <li> <p>GH versus no adjuvant treatment: use of GH in poor responders</p> </li> <li> <p>GH versus no adjuvant treatment: subgroup analysis based on age</p> </li> </ul> </p> </section> <section id="CD000099-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We subgrouped the poor responders as follows.</p> <p> <ul id="CD000099-list-0007"> <li> <p>Women identified as poor responders by definition or based on test results showing low ovarian reserve who did not have IVF cycle before </p> </li> <li> <p>Women identified as poor responders based on previous poor response in IVF stimulation cycle </p> </li> </ul> </p> <p>If we identified substantial heterogeneity, we planned to explore methodological and clinical differences between the trials </p> </section> <section id="CD000099-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted sensitivity analyses for the primary outcomes to determine whether the conclusions are robust to arbitrary decisions made regarding eligibility and analysis. These analyses considered whether conclusions would have differed under the following circumstances. </p> <p> <ul id="CD000099-list-0008"> <li> <p>If eligibility was restricted to trials without high risk of bias. Risk of bias assessment conducted as per Cochrane RoB 1 tool (<a href="./references#CD000099-bbs2-0077" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). Serial exclusion of each study from the meta‐analysis did not produce significant changes in any outcome. </p> </li> <li> <p>If trials with outlying results had been excluded. Serial exclusion of each study from the meta‐analysis did not produce significant changes in any outcome. </p> </li> <li> <p>If a random‐effects model had been adopted. Changing from fixed‐effect to random‐effects model did not change the conclusions, but the results showed wider CIs. </p> </li> <li> <p>If a sensitivity analysis was performed to detect whether the inclusion of RCTs with high numbers of participants affected the results. Serial exclusion of each study from the meta‐analysis did not produce significant changes in any outcome. </p> </li> </ul> </p> </section> <section id="CD000099-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We prepared a summary of findings table using GRADEpro GDT and Cochrane methods (<a href="./references#CD000099-bbs2-0074" title="GRADEpro GDT. Version accessed 10 April 2020. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available at gradepro.org. [.Available at gradepro.org.]">GRADEpro GDT 2015</a>; <a href="./references#CD000099-bbs2-0078" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>; <a href="./references#CD000099-bbs2-0090" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.">Schünemann 2013</a>). We prepared two summary of findings tables for GH compared to no adjuvant in: i) normal responders; and ii) poor responders. Each table evaluated the overall certainty of the body of evidence for live birth rate, clinical pregnancy rate, number of women with at least one oocyte retrieved, mean number of oocytes retrieved, embryo transfer rate, mean units of gonadotrophin used, and adverse events for adjuvant GH treatment versus no adjuvant in normal responders. We assessed the certainty of the evidence using GRADE criteria (<a href="./references#CD000099-bbs2-0090" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.">Schünemann 2013</a>): risk of bias, consistency of effect, imprecision, indirectness and publication bias). Two review authors (AS and LM) working independently made judgements about evidence quality (high, moderate, low or very low), with disagreements resolved by discussion. We justified, documented, and incorporated judgements into reporting of results for each outcome. </p> <p>We extracted the study data, formatting our comparisons in data tables and prepared the summary of findings tables before writing the results and conclusions of our review. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD000099-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD000099-sec-0039"></div> <section id="CD000099-sec-0040"> <h3 class="title">Description of studies</h3> <p>We only included randomised controlled trials (RCTs) with growth hormone (GH) used as an adjuvant treatment for ovarian stimulation with the control group using placebo or no placebo. </p> <section id="CD000099-sec-0041"> <h4 class="title">Results of the search</h4> <p>We included 16 RCTs in the meta‐analysis. The search retrieved 436 articles. After removing duplicates, 304 abstracts were screened. Fifty five studies were potentially eligible and were retrieved in full text. Sixteen studies met our inclusion criteria. We excluded 35 studies, 4 are awaiting classification and 7 are ongoing. See study tables: <a href="./references#CD000099-sec-0117" title="">Characteristics of included studies</a>; <a href="./references#CD000099-sec-0118" title="">Characteristics of excluded studies</a>; <a href="./references#CD000099-sec-0119" title="">Characteristics of studies awaiting classification</a>; <a href="./references#CD000099-sec-0120" title="">Characteristics of ongoing studies</a>; <a href="#CD000099-tbl-0004">Table 2</a>. For details of the screening and selection process see <a href="#CD000099-fig-0001">Figure 1</a>. </p> <div class="table" id="CD000099-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Trial characteristics</span></div> <tbody> <tr> <th align="center" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Trial</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Age</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Poor response type</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>GH</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Dose</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Schedule</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Placebo</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>ET day</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>GH</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Total</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>BMI</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Protocol</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Control</b> </p> </th> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 38</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Response x 2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1 IU/kg</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pre‐ treatment for 7 days followed by with/without stimulation</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Saline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Day 2/3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 x 4 groups</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 40</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Bologna</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Sustained‐release GH</p> <p>Antagonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>20 mg</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3 doses ‐ previous cycle mid luteal, late luteal and D2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not stated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>62</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>127</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 30</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>≥ 40</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Bologna</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>7.5 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Daily from D21 of previous cycle</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 3 up to 3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>120</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>240</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>120</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Response</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Flare</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>18 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Days 2, 4, 6, 8</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Mannitol</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>14</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 39</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Oocyte dysmorphia<br/>&gt; 50% </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3 groups 4 IU, 8 IU, placebo</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Daily from day 1 of stimulation until trigger</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Yes ‐ not stated what</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>4 IU: 12</p> <p>8 IU: 11</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>35</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Response</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>12 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Daily from D21 of previous cycle</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>31</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>61</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>≥ 40</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Bologna</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist ultra‐long protocol</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>4 IU, 4 IU, 2 IU ‐ total 10 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3 consecutive days with stimulation</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>94</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>184</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>25‐38</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Response</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Antagonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>4 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>D2 until 1 day before egg collection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Saline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 2/3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>78</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>156</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 41</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Response</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Antagonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>12 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>D1 until 1 day before egg collection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Metacresol in water</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not stated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>65</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>130</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 33</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 38</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Response</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>24 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Alternate day from D1 stimulation<br/>(maximum 2 weeks) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Yes ‐ not stated what</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 2 (1‐4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>13</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>25</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Bologna</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Antagonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3 groups: <br/>7.5 IU from day 8 <br/>0.3 IU from day 3 previous cycle <br/>saline from day 8 </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3 groups: <br/>7.5 IU from day 8 X 5 d </p> <p>0.3 IU from day 3 previous cycle x 20 d</p> <p>saline from day 8 X 5 d</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Saline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 5 up to 3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group 1: 34</p> <p>Group 2: 32</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>105</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group 3: 26</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 40</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Response x 2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Flare</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3 groups 4 IU, 12 IU, placebo</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Daily from day 3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Saline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>4 IU: 10</p> <p>12 IU: 6</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>22</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 27</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>27‐37</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>N</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Flare</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>24 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Alternate day from D4 stimulation until last HMG</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Saline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not stated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>38</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&gt; 40</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>As per study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>8 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Daily from D7 of stimulation until 1 day before egg collection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Yes ‐ not stated what</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 3 (1‐5)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>50</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>100</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 38</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>N</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>12 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Days 1, 3, 5, 7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Mannitol</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not stated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>42</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Response</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>12 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Alternate day</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not stated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>12</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>27</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p> <ul id="CD000099-list-0009"> <li> <p>HMG: human menopausal gonadotropin</p> </li> <li> <p>IU: international units</p> </li> <li> <p>HGH: human recombinant growth hormone</p> </li> <li> <p>GH: growth hormone</p> </li> </ul> </p> </div> </div> <div class="figure" id="CD000099-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="original image" data-id="CD000099-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD000099-sec-0042"> <h4 class="title">Included studies</h4> <section id="CD000099-sec-0043"> <h5 class="title">Design</h5> <p>We included 16 parallel‐group RCTs in this review (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a>; <a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a>; <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a>; <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a>; <a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>; <a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>). Further descriptive details about the included trials are provided in <a href="./references#CD000099-sec-0117" title="">Characteristics of included studies</a>. All included trials were published reports either as full papers or as conference abstracts (<a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a>). </p> <p>There are 4 studies on which we are awaiting further information (<a href="./references#CD000099-bbs2-0052" title="BassiounyYA , DakhlyDM , BayoumiYA , HashishNM . Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial. Fertility and Sterility2016;105(3):697-702. ">Bassiouny 2016</a>; <a href="./references#CD000099-bbs2-0053" title="BayoumiY , DakhlyDMR , BassiounyY , HashishN . Addition of growth hormone to the micro flare stimulation protocol among women with poor ovarian response. International Journal of Gynaecology and Obstetrics2015;131:305-8. ">Bayoumi 2015</a>; <a href="./references#CD000099-bbs2-0054" title="EftekharM , AflatoonianA , MohammadianF , EftekharT . Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology. Archives of Gynecology and Obstetrics2013;287:1017-21. ">Eftekhar 2012</a>; <a href="./references#CD000099-bbs2-0055" title="GongY , ZhangK , XiongD , WeiJ , TanH , QinS . Growth hormone alleviates oxidative stress and improves the IVF outcomes of poor ovarian responders: a randomised controlled trial. Reproductive Biology and Endocrinology2020;18(91):1-10. [PMID: https://doi.org/10.1186/s12958-020-00648-2]">Gong 2020</a>). Further details for these are available under <a href="./references#CD000099-sec-0119" title="">Characteristics of studies awaiting classification</a>. </p> <p>In addition, there are 7 ongoing trials for which the results are awaited: (<a href="./references#CD000099-bbs2-0056" title="ChiCTR1800016106. Application of Growth Hormone in Patients with Poor Ovarian Response and Study of Mechanism [Application of Growth Hormone in Patients with Poor Ovarian Response and Study of Mechanism]. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1800016106 (first received 11 May 2018). ">ChiCTR1800016106</a>; <a href="./references#CD000099-bbs2-0057" title="CTRI/2019/03/018047. Study to compare the effect of giving growth hormone in poor responders during IVF [Assisted reproductive technique outcomes after growth hormone supplementation in poor responders undergoing in-vitro fertilisation- a randomized controlled trial]. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2019/03/018047 (First received 12 March 2019). ">CTRI/2019/03/018047</a>; <a href="./references#CD000099-bbs2-0058" title="NCT01715324. Adjuvant Growth Therapy in in Vitro Fertilization [Adjuvant Growth Therapy in in Vitro Fertilization: A Randomized Control Trial]. https://clinicaltrials.gov/ct2/show/study/NCT01715324?term=NCT01715324&amp;draw=2&amp;rank=1 (First received 24 Oct 2012). [NCT01715324]">NCT01715324</a>; <a href="./references#CD000099-bbs2-0059" title="NCT02179255. Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF [An Open-Label Randomized Controlled Trial (RCT) of 6 Weeks of Human Growth Hormone (HGH) Prior to Ovulation Induction for In Vitro Fertilization (IVF)]. https://clinicaltrials.gov/ct2/show/study/NCT02179255?term=NCT02179255&amp;draw=2&amp;rank=1 (First received 15 Jun 2014). ">NCT02179255</a>; <a href="./references#CD000099-bbs2-0060" title="NCT03027843. The Effect of Growth Hormone in Assisted Reproductive Technology Clinical Outcome of Poor Responder [A Pilot Study of the Effect of Growth Hormone in Assisted Reproductive Technology Clinical Outcome of Poor Responder]. https://clinicaltrials.gov/ct2/show/NCT03027843?term=NCT03027843&amp;draw=2&amp;rank=1 (First received 13 Jan 2017). ">NCT03027843</a>; <a href="./references#CD000099-bbs2-0061" title="NCT03373149. Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response [Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response]. https://clinicaltrials.gov/ct2/show/NCT03373149?term=NCT03373149&amp;draw=2&amp;rank=1 (First received 7 Dec 2017). ">NCT03373149</a>; <a href="./references#CD000099-bbs2-0062" title="NCT03759301. Efficacy of Growth Hormone Supplementation With Gonadotrophins in IVF/ICSI for Poor Responders [Efficacy of Growth Hormone Supplementation With Gonadotrophins in IVF/ICSI for Poor Responders; a Randomized Controlled Trial]. https://clinicaltrials.gov/ct2/show/NCT03759301?term=NCT03759301&amp;draw=2&amp;rank=1 (First received 22 Nov 2018). ">NCT03759301</a>). The details for these trials are provided in <a href="./references#CD000099-sec-0120" title="">Characteristics of ongoing studies</a>. </p> </section> <section id="CD000099-sec-0044"> <h5 class="title">Participants</h5> <p>We included 16 trials with a total of 1352 subfertile couples in the review. The number of couples included in each trial ranged from 14 in <a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a> to 240 in <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>. </p> <p>Two trials included women who were not identified as poor responders (<a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>). The other 14 trials were conducted in poor responders. The subgroups were as follows. </p> <p> <ul id="CD000099-list-0010"> <li> <p>Poor responder by definition/test results showing low ovarian reserve</p> <ul id="CD000099-list-0011"> <li> <p>Over 40 years old (<a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>) </p> </li> <li> <p>ESHRE criteria</p> <ul id="CD000099-list-0012"> <li> <p>age &gt; 40 years</p> </li> <li> <p>previous treatment that resulted with &lt; 3 oocytes</p> </li> <li> <p>anti‐Müllerian hormone level &lt; 0.5 ng/mL to 1.1 ng/mL</p> </li> <li> <p>antral follicle count &lt; 5 to 7 follicles (<a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a>) </p> </li> </ul> </li> <li> <p>Bologna criteria</p> <ul id="CD000099-list-0013"> <li> <p>age ≥ 40 years or other factor for poor ovarian response</p> </li> <li> <p>previous poor ovarian response (≤ 3 oocytes on ovulation induction)</p> </li> <li> <p>low ovarian reserve test (anti‐Müllerian hormone level &lt; 0.5 ng/mL to 1.1 ng/mL</p> </li> <li> <p>antral follicle count &lt; 5 to 7 follicles (<a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>) </p> </li> </ul> </li> </ul> </li> <li> <p>Poor responder based on previous low response to ovarian stimulation</p> <ul id="CD000099-list-0014"> <li> <p>&lt; 3 oocytes retrieved in previous cycle or at least 48 ampoules of human menopausal gonadotrophin (hMG) used (<a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a>) </p> </li> <li> <p>&lt; 5 oocytes retrieved and &gt; 250 IU follicle stimulating hormone (FSH) in previous cycle (<a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>) </p> </li> <li> <p>≥ 2 previous cycles with &lt; 5 oocytes retrieved (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>) </p> </li> <li> <p>&lt; 6 oocytes retrieved and &lt; 3 embryos developed in previous cycle (<a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>) </p> </li> <li> <p>Previous poor response (not further defined) (<a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>) </p> </li> <li> <p>History of oocyte dysmorphia (<a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a>) </p> </li> <li> <p>Previous low response to high‐dose gonadotrophin treatment (<a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>) </p> </li> <li> <p>Oestradiol &lt; 500 pg/mL, &lt; 3 oocytes retrieved in two previous IVF cycles (<a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a>) </p> </li> <li> <p>IVF in previous poor responders with ≥ 2 failed cycles with &lt; 5 oocytes (<a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>) </p> </li> </ul> </li> </ul> </p> <p>Exclusion criteria were not stated in <a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a>, <a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a>, <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>, <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>, <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a> and <a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>. The remaining trials based their exclusion criteria on serum FSH concentrations (<a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>), obesity (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>), ovarian pathology (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>), endometriosis (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>), severe intercurrent illness (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>), and unsatisfactory sperm quality (<a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>). Women with high FSH levels (&gt; 20 IU/L), a history of infertility due to other causes such as azoospermia and diabetes (type 1 or 2) were excluded in <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>. </p> </section> <section id="CD000099-sec-0045"> <h5 class="title">Interventions</h5> <p>There was no consistency as to the dose or timing of GH administration (see <a href="./references#CD000099-sec-0117" title="">Characteristics of included studies</a> tables). The dose of GH ranged from 4 IU in <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a> and <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a> to 24 IU in <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a> and <a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>. Both <a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a> and <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a> conducted a multiple‐arm study comparing two different doses of GH to a placebo arm, and their data have been reported separately in the analyses, with explanatory footnotes. The timing of GH administration varied between trials from daily administration prestimulation to alternate doses after the start of stimulation. Sustained‐release GH preparation was used by <a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>; all other trials used recombinant GH. </p> <p>Placebo was not used in five trials (<a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a>; <a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>). The remaining 11 trials used placebo in the control group: five used saline (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a>; <a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>), two used mannitol (<a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>), one used metacresol in water (<a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>), and in three trials the nature of placebo used was not stated (<a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>). </p> </section> <section id="CD000099-sec-0046"> <h5 class="title">Outcomes</h5> <section id="CD000099-sec-0047"> <h6 class="title">Primary outcome measure</h6> <p>Live birth rates were reported in 10 of the included trials (<a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a>; <a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>; <a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>). </p> </section> <section id="CD000099-sec-0048"> <h6 class="title">Secondary outcome measures</h6> <p>Pregnancy rates were reported in 13 of the included trials (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a>; <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a>; <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>; <a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>). The number of oocytes retrieved per women was reported in 15 trials, except <a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a>, where SD was not mentioned, hence data could not be used. Adverse events were reported in 10 trials (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a>; <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a>; <a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>). </p> </section> </section> </section> <section id="CD000099-sec-0049"> <h4 class="title">Excluded studies</h4> <p>Thirty five studies were excluded from the review, for the following reasons:</p> <p> <ul id="CD000099-list-0015"> <li> <p>17/35 were not RCTs</p> </li> <li> <p>12/35 were not done in women undergoing IVF (ineligible population)</p> </li> <li> <p>4/35 had used more than 1 adjuvant treatment</p> </li> <li> <p>1/35 had insufficient data</p> </li> <li> <p>1/35 had used ineligible drug</p> </li> </ul> </p> </section> </section> <section id="CD000099-sec-0050"> <h3 class="title">Risk of bias in included studies</h3> <p>Please refer to <a href="./references#CD000099-sec-0117" title="">Characteristics of included studies</a> table, <a href="#CD000099-fig-0002">Figure 2</a> and <a href="#CD000099-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD000099-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included trials." data-id="CD000099-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included trials. </p> </div> </div> </div> <div class="figure" id="CD000099-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD000099-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> <section id="CD000099-sec-0051"> <h4 class="title">Allocation</h4> <section id="CD000099-sec-0052"> <h5 class="title">Random sequence generation</h5> <p>The method of randomisation was clearly stated in seven trials and we assessed them at low risk of selection bias (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>; <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>). The method of randomisation was unclear in the remaining trials. </p> </section> <section id="CD000099-sec-0053"> <h5 class="title">Allocation concealment</h5> <p>Five studies were rated as at low risk of selection bias related to allocation concealment as they used sequentially labelled, sealed, opaque envelopes (<a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>). No allocation concealment was described in 3 studies, which we rated as high risk of bias for this domain (<a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a>; <a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>). The other eight studies failed to describe methods of allocation concealment or opaque envelopes were not used and we rated these as at unclear risk of bias for this domain. </p> </section> </section> <section id="CD000099-sec-0054"> <h4 class="title">Blinding</h4> <p>We did not consider that blinding of participants and personnel was likely to influence findings for the primary review outcome (live birth rate). Eleven trials were rated as low risk for selection bias related to blinding; among which two trials reported single‐blinding (<a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>; <a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>), seven trials were double‐blinded (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a>; <a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>), and two trials reported triple‐blinding (<a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>). The remaining 5 trials were not blinded. </p> </section> <section id="CD000099-sec-0055"> <h4 class="title">Incomplete outcome data</h4> <p>Two women were lost to follow‐up in the <a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a> study and four women were lost to follow‐up in the <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a> study, and both these were rated as high risk of attrition bias. Also, 3 studies with &gt; 10% cycle cancellation rate were rated as high risk of attrition bias (<a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>). The remaining trials reported no losses and had a cycle cancellation rate &lt; 10%. </p> </section> <section id="CD000099-sec-0056"> <h4 class="title">Selective reporting</h4> <p>Six trials were rated as high risk of selective reporting as these did not report adverse events (<a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a>; <a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>, <a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>). A registered protocol was available for four trials (<a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>, <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>, <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>), 3 of these were rated as low risk of selection bias; adverse effects were not reported by <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>. We rated the remaining 7 studies as at unclear risk of bias although they reported our review’s primary outcomes; we could not obtain a study protocol and the study was not prospectively registered so there was no information we could use to verify study details. </p> </section> <section id="CD000099-sec-0057"> <h4 class="title">Other potential sources of bias</h4> <p>Five trials have been rated as high risk: three trials received a free supply of GH from the manufacture (<a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>), one trial received a grant (<a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>) and one trial had very low numbers (<a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a>). Five trials have been rated as unclear risk of this bias: placebo was not used in four (<a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a>; <a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>) and one was a conference abstract (<a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a>). Placebo was not used in <a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a> as well but this has been rated as high risk. No other bias was noted in the remaining six trials. </p> </section> </section> <section id="CD000099-sec-0058"> <h3 class="title" id="CD000099-sec-0058">Effects of interventions</h3> <p>See: <a href="./full#CD000099-tbl-0001"><b>Summary of findings 1</b> Adjuvant growth hormone compared to no adjuvant: routine use for in vitro fertilisation (IVF)</a>; <a href="./full#CD000099-tbl-0002"><b>Summary of findings 2</b> Adjuvant growth hormone compared to no adjuvant: poor responders for in vitro fertilisation (IVF)</a> </p> <section id="CD000099-sec-0059"> <h4 class="title">1 Adjuvant growth hormone compared to no adjuvant or placebo: routine use for IVF</h4> <section id="CD000099-sec-0060"> <h5 class="title">Primary outcomes</h5> <section id="CD000099-sec-0061"> <h6 class="title">1.1 Live birth rate per woman randomised</h6> <p>Only two of the RCTs were conducted in women who were not identified as poor responders (<a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>). The evidence is very uncertain about the effect of GH on live birth rate per woman randomised for routine use in IVF (odds ratio (OR) 1.32, 95% confidence interval (CI) 0.40 to 4.43; I<sup>2</sup> = 0%; 2 trials, 80 participants; very low‐certainty evidence) <a href="./references#CD000099-fig-0011" title="">Analysis 1.1</a>, <a href="#CD000099-fig-0004">Figure 4</a>). If the chance of live birth without use of GH as adjuvant is assumed to be 15%, the chance of live birth with use of GH would be between 6% and 43%. </p> <div class="figure" id="CD000099-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Adjuvant GH compared to no adjuvant: routine use for IVF, outcome: 1.1 Live birth rate per woman randomised." data-id="CD000099-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Adjuvant GH compared to no adjuvant: routine use for IVF, outcome: 1.1 Live birth rate per woman randomised. </p> </div> </div> </div> </section> </section> <section id="CD000099-sec-0062"> <h5 class="title">Secondary outcomes</h5> <section id="CD000099-sec-0063"> <h6 class="title">1.2 Clinical pregnancy rate per woman randomised</h6> <p>Only one RCT was conducted in women who were not identified as poor responders (<a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>), hence we could not perform meta‐analysis (<a href="./references#CD000099-fig-0012" title="">Analysis 1.2</a>). </p> </section> <section id="CD000099-sec-0064"> <h6 class="title">1.3 Number of women with at least one oocyte retrieved per woman randomised</h6> <p>One trial reported number of women with at least one oocyte retrieved (<a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>), hence we could not perform meta‐analysis (<a href="./references#CD000099-fig-0013" title="">Analysis 1.3</a>). </p> </section> <section id="CD000099-sec-0065"> <h6 class="title">1.4 Mean number of oocytes retrieved</h6> <p>Two trials reported the mean number of oocytes retrieved per woman randomised (<a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>). The evidence is very uncertain about the effect of GH on mean number of oocytes retrieved in normal responders (mean difference (MD) ‐0.02, 95% CI ‐0.79 to 0.74; I<sup>2</sup> = 0%; 2 trials, 80 participants; very low‐certainty evidence) ( <a href="./references#CD000099-fig-0014" title="">Analysis 1.4</a>). The mean number of oocytes retrieved were 6 to 13. </p> </section> <section id="CD000099-sec-0066"> <h6 class="title">1.5 Embryo transfer per woman randomised</h6> <p>One trial reported the number of embryos transferred per woman randomised (<a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>), hence we could not perform meta‐analysis (<a href="./references#CD000099-fig-0015" title="">Analysis 1.5</a>). </p> </section> <section id="CD000099-sec-0067"> <h6 class="title">1.6 Mean units of gonadotrophin used</h6> <p>Two trials reported the mean number of ampoules of gonadotrophin used per woman randomised (<a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>). We converted the ampoules into units for standardisation throughout the review. We are uncertain if the mean number of ampoules of gonadotropin used changed with GH in IVF protocols when compared to standard IVF protocols (MD 13.57, 95% CI ‐112.88 to 140.01; I<sup>2</sup> = 0%; 2 trials, 80 participants; very low‐certainty evidence; <a href="./references#CD000099-fig-0016" title="">Analysis 1.6</a>). </p> </section> <section id="CD000099-sec-0068"> <h6 class="title">1.7 Adverse events</h6> <p>Low‐certainty evidence suggests that GH does not increase or reduce adverse events in normal responders. Adverse events were reported by <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a> and <a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>. <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a> reported ectopic pregnancy 0/20 in GH group and 2/22 in control group, multiple pregnancy 5/20 in GH group and 2/22 in control group, ovarian hyperstimulation syndrome (OHSS) 0/20 in GH group and 0/22 in control group. <a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a> reported multiple pregnancy 0/19 in GH group and 1/19 in control group. Other adverse events were not reported (<a href="./full#CD000099-tbl-0003">Table 1</a>). </p> </section> </section> </section> <section id="CD000099-sec-0069"> <h4 class="title">2 Adjuvant GH compared to no adjuvant or placebo: poor responders for IVF</h4> <section id="CD000099-sec-0070"> <h5 class="title">Primary outcome</h5> <section id="CD000099-sec-0071"> <h6 class="title">2.1 Live birth rate per woman randomised</h6> <p>Eight trials reported the live birth rate per woman randomised (<a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>; <a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>). The evidence is very uncertain about the effect of GH on live birth rate per woman randomised for poor responders (OR 1.77, 95% CI 1.17 to 2.70; I<sup>2</sup> = 0%; 8 trials, 737 participants; very low‐certainty evidence; <a href="./references#CD000099-fig-0017" title="">Analysis 2.1</a>, <a href="#CD000099-fig-0005">Figure 5</a>). If the chance of live birth without use of GH as adjuvant is assumed to be 11%, the chance of live birth with use of GH would be between 13% and 25%. </p> <div class="figure" id="CD000099-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Growth hormone versus no adjuvant: poor responders, outcome: 2.1 Live birth rate per woman randomised." data-id="CD000099-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Growth hormone versus no adjuvant: poor responders, outcome: 2.1 Live birth rate per woman randomised. </p> </div> </div> </div> <section id="CD000099-sec-0072"> <p><b>Subgroup analysis</b></p> <p>Live birth rates in the poor responder by definition subgroup (<a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>), evidence is uncertain if adjuvant GH increases live birth rates (OR 1.85, 95% CI 1.02 to 3.38; I<sup>2</sup> = 46%; 3 trials, 400 participants); and in the poor responder based on previous response subgroup (<a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a>; <a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>), evidence is uncertain if adjuvant GH increases live birth rates (OR 1.70, 95% CI 0.95 to 3.06; I<sup>2</sup> = 0%; 5 trials, 337 participants). </p> <p>We did not find evidence that the treatment effect differed between the groups of studies (test for subgroup differences: Chi² = 0.04, df = 1 (P = 0.84), I² = 0%). </p> </section> </section> </section> <section id="CD000099-sec-0073"> <h5 class="title">Secondary outcomes</h5> <section id="CD000099-sec-0074"> <h6 class="title">2.2 Clinical pregnancy rate per woman randomised</h6> <p>Eleven trials reported the pregnancy birth rate per woman randomised (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a>; <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a>; <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>; <a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>). GH used as adjuvant results in a slight increase in pregnancy rates per woman randomised in poor responders (OR 1.85, 95% CI 1.35 to 2.53; I<sup>2</sup> = 15%; 11 trials, 1033 participants; low‐certainty evidence; <a href="./references#CD000099-fig-0018" title="">Analysis 2.2</a>; <a href="#CD000099-fig-0006">Figure 6</a>). The results suggest, if the pregnancy rate without adjuvant GH is assumed to be 15%, with GH use, the pregnancy rate in poor responders would be between 19% and 31%. </p> <div class="figure" id="CD000099-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Growth hormone versus no adjuvant: poor responders, outcome: 2.2 Pregnancy rate per woman randomised." data-id="CD000099-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-06.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Growth hormone versus no adjuvant: poor responders, outcome: 2.2 Pregnancy rate per woman randomised. </p> </div> </div> </div> <section id="CD000099-sec-0075"> <p><b>Subgroup analysis</b></p> <p>In both subgroups, pregnancy rates probably increased in women who received adjuvant GH. Poor responder by definition group: OR 1.70, 95% CI 1.16 to 2.50; I<sup>2</sup> = 59%; 5 trials, 711 participants; and the poor responder based on previous response group: OR 2.19, 95% CI 1.26 to 3.81; I<sup>2</sup> = 0%; 6 trials, 322 participants; <a href="./references#CD000099-fig-0018" title="">Analysis 2.2</a>). </p> <p>We did not find evidence that the treatment effect differed between the groups of studies (test for subgroup differences: Chi² = 0.53, df = 1 (P = 0.46), I² = 0%). </p> </section> </section> <section id="CD000099-sec-0076"> <h6 class="title">2.3 Number of women with at least one oocyte retrieved per woman randomised</h6> <p>Two trials reported number of women with at least 1 oocyte retrieved per woman randomised (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>). The evidence suggests that GH results in little to no difference in the number of women with at least one oocyte retrieved per woman randomised (OR 5.67, 95% CI 1.54 to 20.83; I<sup>2</sup> = 0; 2 trials, 148 participants; low‐certainty evidence; <a href="./references#CD000099-fig-0019" title="">Analysis 2.3</a>). If the chance of retrieving at least one oocyte in poor responders was 81%, with GH the chance is between 87% and 99%. </p> </section> <section id="CD000099-sec-0077"> <h6 class="title">2.4 Mean number of oocytes retrieved</h6> <p>Twelve trials reported number of oocytes retrieved (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a>; <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a>; <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>). <a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a> reported the mean numbers but standard deviation (SD) was not mentioned, hence data could not be used in the analysis. There is a slight increase in the mean number of oocytes retrieved with the use of GH for poor responders (MD 1.40, 95% CI 1.16 to 1.64; I<sup>2</sup> = 87%; 12 trials, 1153 participants; low‐certainty evidence; <a href="./references#CD000099-fig-0020" title="">Analysis 2.4</a>). The mean number of oocytes retrieved were 2 to 6. However heterogeneity of over 85% suggests quite different effects according to differences including in trial protocols (populations, GH dose and schedule), so the result should be interpreted with caution. </p> <p>We did not find evidence that the treatment effect differed between the groups of studies (test for subgroup differences: Chi² = 0.08, df = 1 (P = 0.77), I² = 0%). </p> </section> <section id="CD000099-sec-0078"> <h6 class="title">2.5 Embryo transfer achieved per woman randomised</h6> <p>Four trials reported embryo transfer per woman randomised (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a>). The evidence is very uncertain about the effect of GH on embryo transfer achieved per woman randomised (OR 2.32, 95% CI 1.08 to 4.96; I<sup>2</sup> = 25%; 4 trials, 214 participants; very low‐certainty evidence; <a href="./references#CD000099-fig-0021" title="">Analysis 2.5</a>). If the chance of achieving embryo transfer per woman randomised is assumed to be 77%, the chance with use of GH will be 78% to 94%. </p> </section> <section id="CD000099-sec-0079"> <h6 class="title">2.6 Mean units of gonadotrophin used</h6> <p>Eight trials reported mean units of gonadotropin used (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a>; <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>). Use of GH results in reduction of mean units of gonadotropins used for stimulation in poor responders (MD ‐1088.19, 95% CI ‐1203.20 to ‐973.18; I<sup>2</sup> = 91%; 8 trials, 685 participants; low‐certainty evidence; <a href="./references#CD000099-fig-0022" title="">Analysis 2.6</a>). However amongst studies including poor responders based on a definition there was considerable heterogeneity, such that the pooled estimate may not represent a useful summary. </p> <p>The test for subgroup differences showed that treatment effect differed between the groups of trials (Chi² = 14.41, df = 1 (P = 0.0001), I² = 93.1%). </p> </section> <section id="CD000099-sec-0080"> <h6 class="title">2.7 Adverse events</h6> <p>Six trials did not report adverse events (<a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a>; <a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>, <a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>). <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a> reported ectopic pregnancies: 0/13 in GH group and 1/12 in control; the other trials in poor responder group reported no cases of ectopic pregnancy in either group. Multiple pregnancy was reported in <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>: 2/13 in GH group and 0/12 in control group; <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a> reported 1/78 in GH group and 1/78 in control group; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a> reported 1/10 in 4 IU GH group and 0/6 in control group; and other trials reported no cases of multiple pregnancies in either group. <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a> reported congenital anomalies: 1/65 in GH group and 1/65 in control group; other trials reported no cases of congenital anomalies in either group. <a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a> reported that 2/29 cases in GH group had oedema, but this outcome was not reported by any other study. <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>, <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a> and <a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a> reported that no adverse events were seen in either group. This information has been presented in tabular form in <a href="./full#CD000099-tbl-0003">Table 1</a>. </p> </section> <section id="CD000099-sec-0081"> <h6 class="title">2.8 Other analyses</h6> <p>We conducted sensitivity analyses for the primary outcome, live birth rate, to determine whether the conclusions are robust to arbitrary decisions made regarding eligibility and analysis. These analyses considered whether conclusions would have differed under the following circumstances. </p> <p> <ul id="CD000099-list-0016"> <li> <p>If eligibility was restricted to trials without high risk of bias. Risk of bias assessment conducted as per Cochrane RoB 1 tool (<a href="./references#CD000099-bbs2-0077" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). Serial exclusion of each study from the meta‐analysis did not produce significant changes in this outcome. </p> </li> <li> <p>If trials with outlying results had been excluded. Serial exclusion of each study from the meta‐analysis did not produce significant changes in this outcome. </p> </li> <li> <p>If a random‐effects model had been adopted. Changing from fixed‐effect to random‐effects model did not change the conclusions, but the results showed wider CIs. </p> </li> <li> <p>If a sensitivity analysis was performed to detect whether the inclusion of RCTs with high numbers of participants affected the results. Serial exclusion of each study from the meta‐analysis did not produce significant changes in this outcome. </p> </li> </ul> </p> </section> </section> </section> <section id="CD000099-sec-0082"> <h4 class="title">3 Adjuvant GH compared to no adjuvant or placebo: subgroup analysis based on age</h4> <section id="CD000099-sec-0083"> <h5 class="title">3.1 Live birth rate per woman randomised</h5> <p>Ten trials reported the live birth rate per woman randomised (<a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>; <a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>; <a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>). </p> <p>Subgroup analysis based on age showed that it is uncertain if adjuvant GH increases live birth rates both in &lt; 40 years group (OR 1.45, 95% CI 0.82 to 2.56; I<sup>2</sup> = 0%; 6 trials, 390 participants) and &gt; 40 years group (OR 1.69, 95% CI 0.90 to 3.20; I<sup>2</sup> = 72%; 2 trials, 340 participants; <a href="./references#CD000099-fig-0023" title="">Analysis 3.1</a>, <a href="#CD000099-fig-0007">Figure 7</a>). High heterogeneity was noted in the subgroup &gt; 40 years, suggesting different effects according to differences including in trial protocols (populations, GH dose and schedule). </p> <div class="figure" id="CD000099-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="original image" data-id="CD000099-fig-0007" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-07.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> <p>We did not find evidence that the treatment effect differed between the groups of studies (test for subgroup differences: Chi² = 1.71, df = 2 (P = 0.43), I² = 0%). </p> </section> <section id="CD000099-sec-0084"> <h5 class="title">Secondary outcomes</h5> <section id="CD000099-sec-0085"> <h6 class="title">3.2 Clinical pregnancy rate per woman randomised</h6> <p>Twelve trials reported the pregnancy birth rate per woman randomised (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a>; <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a>; <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>; <a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>). </p> <p>On conducting further subgroup analysis based on age, pregnancy rates were slightly improved in &lt; 40 years of age (OR 1.98, 95% CI 1.12 to 3.50; I<sup>2</sup> = 0%; 5 trials, 288 participants) be it in poor responder or normal responder, but this was not seen in the age group &gt; 40 years (OR 1.64, 95% CI 1.11 to 2.42; I<sup>2</sup> = 67%; 4 trials, 651 participants; <a href="./references#CD000099-fig-0024" title="">Analysis 3.2</a>, <a href="#CD000099-fig-0008">Figure 8</a>). There is high heterogeneity noted in clinical pregnancy rates in the &gt; 40 years subgroup, suggesting different effects according to differences including in trial protocols, study population and also difference in GH dose and schedule. </p> <div class="figure" id="CD000099-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="original image" data-id="CD000099-fig-0008" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-08.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> <p>We did not find evidence that the treatment effect differed between the groups of studies (test for subgroup differences: Chi² = 0.69, df = 2 (P = 0.71), I² = 0%). </p> </section> <section id="CD000099-sec-0086"> <h6 class="title">3.3 Number of women with at least one oocyte retrieved per woman randomised</h6> <p>Three trials reported number of women with at least 1 oocyte retrieved per woman randomised (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>). </p> <p>On conducting further subgroup analysis based on age, the number of women with at least one oocyte retrieved was higher in those &lt; 40 years of age (OR 5.19, 95% CI 1.56 to 17.32; I<sup>2</sup> = 0; 3 trials, 190 participants; (<a href="./references#CD000099-fig-0025" title="">Analysis 3.3</a>) </p> </section> <section id="CD000099-sec-0087"> <h6 class="title">3.4 Mean number of oocytes retrieved</h6> <p>Fifteen trials reported number of oocytes retrieved (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a>; <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a>; <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>; <a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>). <a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a> reported the mean numbers but standard deviation (SD) was not mentioned, hence data could not be used in the analysis. </p> <p>On further subgroup analysis based on age, there was uncertain effect on mean number of oocytes retrieved in women &lt; 40 years (MD 0.73, 95% CI 0.34 to 1.13; I<sup>2</sup> = 67%; 7 trials, 437 participants; <a href="./references#CD000099-fig-0026" title="">Analysis 3.4</a>), whereas trials with participants &gt; 40 years showed a slight increase in oocytes retrieved (MD 1.35, 95% CI 1.03 to 1.68; I<sup>2</sup> = 94%; 4 trials, 651 participants; <a href="./references#CD000099-fig-0026" title="">Analysis 3.4</a>), and similarly trials in which age criteria were not defined showed a slight increase in oocytes retrieved (MD 2.12, 95% CI 1.55 to 2.69; I<sup>2</sup> = 83%; 4 trials, 172 participants) and the pooled result for all trials showed a slight increase in oocytes retrieved (MD 1.27, 95% CI 1.04 to 1.49; I<sup>2</sup> = 86%; 15 trials, 1260 participants; <a href="./references#CD000099-fig-0026" title="">Analysis 3.4</a>, <a href="#CD000099-fig-0009">Figure 9</a>). There is high heterogeneity noted in the number of oocytes retrieved for all subgroups, suggesting different effects according to differences including in trial protocols, study population and also difference in GH dose and schedule. </p> <div class="figure" id="CD000099-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="original image" data-id="CD000099-fig-0009" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-09.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> <p>The test for subgroup differences showed that the treatment effect differed between the groups of trials (Chi² = 16.04, df = 2 (P = 0.0003), I² = 87.5%). </p> </section> <section id="CD000099-sec-0088"> <h6 class="title">3.5 Embryo transfer achieved per woman randomised</h6> <p>Five trials reported embryo transfer per woman randomised (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>). On sub‐group analysis, the evidence is very uncertain about the effect of GH on embryo transfer achieved per woman randomised &lt; 40 years (OR 1.73, 95% CI 0.80 to 3.74; participants = 201; studies = 5; I<sup>2</sup> = 0%); <a href="./references#CD000099-fig-0027" title="">Analysis 3.5</a>. </p> <p>We found evidence that the treatment effect differed between the groups of trials (test for subgroup differences: Chi² = 2.92, df = 2 (P &lt; 0.09), I² = 65.8%). </p> </section> <section id="CD000099-sec-0089"> <h6 class="title">3.6 Mean units of gonadotrophin used</h6> <p>Ten trials reported mean units of gonadotropin used (<a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a>; <a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a>; <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>; <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a>; <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>; <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a>; <a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a>; <a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a>). </p> <p>On further subgroup analysis based on age, there was uncertain effect in &lt; 40 years (MD ‐24.30, 95% CI ‐145.14 to 96.55; participants = 253; studies = 5; I<sup>2</sup> = 34%; <a href="./references#CD000099-fig-0028" title="">Analysis 3.6</a>), whereas trials with participants &gt; 40 years showed a slight reduction in mean units of gonadotropin used (MD ‐782.66, 95% CI ‐1004.35 to ‐560.97; participants = 367; studies = 2; I<sup>2</sup> = 97%; <a href="./references#CD000099-fig-0028" title="">Analysis 3.6</a>), and similarly trials in which age criteria were not defined showed there was a reduction in mean units of gonadotropins used (MD ‐1294.15, 95% CI ‐1436.54 to ‐1151.77; participants = 145; studies = 3; I<sup>2</sup> = 91%; <a href="./references#CD000099-fig-0028" title="">Analysis 3.6</a>) and the pooled result for all trials showed a slight reduction in mean units of gonadotropin used (MD ‐589.38, 95% CI ‐674.47 to ‐504.30; participants = 765; studies = 10; I<sup>2</sup> = 96%);<a href="./references#CD000099-fig-0028" title="">Analysis 3.6</a>. There is high heterogeneity noted in the number of oocytes retrieved for the subgroups of women &gt; 40 years and where the age criteria were not defined, such that the pooled estimates may not represent useful summaries. </p> <p>The test for subgroup differences showed that the treatment effect differed between the groups of trials (Chi² = 181.03, df = 2 (P &lt; 0.00001), I² = 98.9%). </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD000099-sec-0090" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD000099-sec-0090"></div> <section id="CD000099-sec-0091"> <h3 class="title" id="CD000099-sec-0091">Summary of main results</h3> <p>This review was undertaken to establish the role of adjuvant GH therapy for IVF in improving IVF outcomes, particularly in those women who are considered poor responders. We included 16 RCTs (1352 women analysed). Two RCTs (80 women analysed) studied GH in routine use, and 14 RCTs (1272 women analysed) studied GH in poor responders. The evidence was low to very low certainty, with the main limitations being risk of bias, imprecision and heterogeneity. </p> <p><b>Adjuvant growth hormone compared to no adjuvant: routine use for in vitro fertilisation (IVF)</b> </p> <p>The evidence is very uncertain about the effect of GH on live birth rate per woman randomised for routine use in IVF (low‐certainty evidence). There was insufficient evidence to reach a conclusion regarding clinical pregnancy rates per woman randomised, number of women with at least one oocyte retrieved per woman randomised and embryo transfer achieved per woman randomised; reported data were unsuitable for analysis. The evidence is very uncertain about the effect of GH on mean number of oocytes retrieved in normal responders (very low‐certainty evidence). The evidence suggests that GH does not increase or reduce adverse events in normal responders. This information has been presented in tabular form in <a href="./full#CD000099-tbl-0003">Table 1</a>. </p> <p><b>Adjuvant growth hormone compared to no adjuvant: use in poor responders for in vitro fertilisation (IVF)</b> </p> <p>The evidence is very uncertain about the effect of GH on live birth rate per woman randomised for poor responders (very low‐certainty evidence). GH used as adjuvant results in a slight increase in pregnancy rates per woman randomised in poor responders compared to no use of GH (low‐certainty evidence). The evidence suggests that GH results in little to no difference in the number of women with at least one oocyte retrieved per woman randomised (low‐certainty evidence). There is a slight increase in the mean number of oocytes retrieved with the use of GH for poor responders (low‐certainty evidence). The evidence is very uncertain about the effect of GH on embryo transfers achieved per woman randomised (very low‐certainty evidence). Use of GH results in reduction of mean units of gonadotropins used for stimulation in poor responders (low‐certainty evidence). Eight of 14 included trials reported adverse events. These included ectopic pregnancy, multiple pregnancy and congenital abnormality. This information has been presented in tabular form in <a href="./full#CD000099-tbl-0003">Table 1</a>. </p> <p>High heterogeneity in the analyses for mean number of oocytes retrieved and units of GH used suggests quite different effects according to differences including in trial protocols (populations, GH dose and schedule), so these results should be interpreted with caution. </p> </section> <section id="CD000099-sec-0092"> <h3 class="title" id="CD000099-sec-0092">Overall completeness and applicability of evidence</h3> <p>The included trials did not answer the review question satisfactorily. Mainly, the primary outcome, live birth rate, was not reported in all trials. Also, since the dose, preparation and timing of administration of GH varied across the trials, robust conclusions cannot be derived. </p> <p>The causative factors for poor response to controlled ovarian stimulation are not well described in the literature. Consequently, the definitions of a 'poor responder' are varied, ranging from age to poor responders to gonadotrophin stimulation on previous IVF cycles. Therefore the inclusion criteria of the included trials varied greatly. The evidence is low to very low certainty. </p> <p>There was no uniformity of dose, preparation or timing of the intervention, and this can introduce bias (see <a href="#CD000099-tbl-0004">Table 2</a>). Also, the funnel plot could indicate publication bias (<a href="#CD000099-fig-0010">Figure 10</a>), and this can skew the results of the review. Furthermore, some of the included trials had relatively small sample sizes, and this may have influenced the validity and reliability of the conclusions. Finally, not all the included trials had strict methods of randomisation, blinding and allocation concealment, which may affect conclusions. </p> <div class="figure" id="CD000099-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Funnel plot ‐ Preganacy rate per woman randomised in poor responder group." data-id="CD000099-fig-0010" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-10.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot ‐ Preganacy rate per woman randomised in poor responder group.</p> </div> </div> </div> </section> <section id="CD000099-sec-0093"> <h3 class="title" id="CD000099-sec-0093">Quality of the evidence</h3> <p>Of the 16 RCTs included in the review, there were significant differences in the number of participants, variations in the cause of subfertility and variations in the IVF treatment protocol. The dose of GH also varied in the trials and the outcomes measured all varied considerably between the trials. As such, the certainity of evidence is very low due to imprecision, small sample size and heterogeneity. Also, there was asymmetry in the funnel plot (<a href="#CD000099-fig-0010">Figure 10</a>), which could indicate publication bias, or small study effects or use of an inappropriate effect measure. </p> </section> <section id="CD000099-sec-0094"> <h3 class="title" id="CD000099-sec-0094">Potential biases in the review process</h3> <p>The methods established to conduct the current review were agreed by all review authors and any potential bias that could have been introduced was bypassed through independent screening, assessment, selection and data extraction with discrepancies resolved through team consensus. The search was supported by the CGFG Information Specialist. </p> <p>We made every effort to identify all potentially eligible trials, and sought additional data from study authors as necessary. However, it is possible that there are unpublished trials that were not retrieved. </p> <p>Also, there was asymmetry in the funnel plot (<a href="#CD000099-fig-0010">Figure 10</a>), which could indicate publication bias, or small study effects or use of an inappropriate effect measure. </p> </section> <section id="CD000099-sec-0095"> <h3 class="title" id="CD000099-sec-0095">Agreements and disagreements with other studies or reviews</h3> <p>Currently, no national or international guidelines recommend the routine use of GH augmentation in IVF protocols. Unfortunately, due to the problems inherent with recruiting women who have undergone unsuccessful IVF treatment cycles and their inevitable low live birth rate per initiated cycle, many trials performed to date have been underpowered. However, a previous systematic review and meta‐analysis concerning the evaluation of strategies to improve pregnancy rates in poor responders undergoing IVF concluded there was some evidence to suggest the addition of GH could improve live birth rates, but further research was required (<a href="./references#CD000099-bbs2-0082" title="KyrouD , KolibianakisEM , VenetisCA , PapanikolaouEG , BontisJ , TarlatzisBC . How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertility and Sterility2009;91(3):749-66.">Kyrou 2009</a>). Another meta‐analysis demonstrated a benefit for the use of adjunct GH, with a reduction in the duration of ovarian stimulation required for oocyte retrieval, the collection of a greater number of oocytes than placebo, and an improvement in many of the early clinical parameters; however, there was no evidence of an increased chance of a live birth with the use of GH (<a href="./references#CD000099-bbs2-0075" title="HartRJ , RombautsL , NormanRJ . Growth hormone in IVF cycles: any hope?Current Opinion in Obstetrics and Gynecology2017;29(3):119-25.">Hart 2017</a>). Similar conclusions suggesting an increase in clinical pregnancy rate but no increase in live birth rate was also seen in a meta‐analysis in <a href="./references#CD000099-bbs2-0070" title="CozzolinoM , CecchinoGN , TroianoG , RomanelliC . Growth hormone co-treatment for poor responders undergoing in vitro fertilization cycles: a systematic review and meta-analysis. Fertility and Sterility2020;114(1):97-109. [DOI: doi: 10.1016/j.fertnstert.2020.03.007.]">Cozzolino 2020</a>. However, another recent meta‐analysis concluded that GH supplementation might improve live birth rates, clinical pregnancy rates and oocytes retrieved (<a href="./references#CD000099-bbs2-0091" title="YangP , WuR , ZhangH . The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials. Reproductive Biology and Endocrinology2020;18(1):76. [DOI: doi: 10.1186/s12958-020-00632-w.]">Yang 2020</a>). The difference in results could possibly be explained by the further information we are awaiting from trials included in this review. </p> <p>A retrospective analysis based on real‐world data suggests a role for GH in POSEIDON (<b>P</b> atient‐<b>O</b> riented <b>S</b> trategies <b>E</b> ncompassing <b>I</b> ndividualize<b>D</b> <b>O</b> ocyte <b>N</b>umber) group 4 patients (<a href="./references#CD000099-bbs2-0068" title="CaiMH , GaoLZ , LiangXY , FangC , WuYQ , YangX . The effect of growth hormone on the clinical outcomes of poor ovarian reserve patients undergo- ing in vitro fertilization/intracytoplasmic sperm injection treatment: a retrospective study based on POSEIDON criteria. Frontiers in Endocrinology (Lausanne)2019;10:775.">Cai 2019</a>). This is the first publication to detect specific subgroups of poor ovarian responders that would benefit from GH supplementation. The authors explored the effects of GH in the POSEIDON groups 3 and 4, but they were capable of detecting an improvement in live birth rates together with a decrease in miscarriage rates only in POSEIDON group 4. A future prospective trial based on POSEIDON groups with a standardised protocol of GH supplementation may provide further answers. </p> <p>New avenues are being explored for the use of GH in IVF. In a recent study of recurrent implantation failure patients undergoing IVF. The clinical pregnancy and live birth rates in the treatment group were significantly higher than those in the control group (<a href="./references#CD000099-bbs2-0069" title="ChenY , LiuF , NongY , RuanJ , GuoQ , LuoM , et al. Clinical efficacy and mechanism of growth hormone action in patients experiencing repeat implantation failure. Canadian Journal of Physiology and Pharmacology2018;96:929-32.">Chen 2018</a>). The mechanism was postulated to be increased GH receptors in granulosa cells. Another study reported improved implantation, pregnancy, and live birth rates among infertile patients with recurrent implantation failure; treatment with GH suggested that GH improves uterine receptivity (<a href="./references#CD000099-bbs2-0064" title="AltmaeS , Mendoza-TesarikR , MendozaC , MendozaN , CucinelliF , TesarikJ . Effect of growth hormone on uterine receptivity in women with repeated implantation failure in an oocyte donation program: a randomized controlled trial. Journal of the Endocrine Society2018;2(1):96-105. [DOI: 10.1210/js.2017-00359]">Altmae 2018</a>). We await further investigation and clarification from a recently conducted meta‐analysis that questioned whether the role of GH resides in the treatment of poor oocyte quality, the treatment of the 'suboptimal' responder, the treatment of the 'thin endometrium' or 'recurrent implantation failure' (<a href="./references#CD000099-bbs2-0071" title="CuiN , LiAM , LuoZY , ZhaoZM , XuYM , ZhangJ , et al. Effects of growth hormone on pregnancy rates of patients with thin endometrium. Journal of Endocrinological Investigation2019;42:27-35.">Cui 2019</a>; <a href="./references#CD000099-bbs2-0076" title="HartRJ . Use of growth hormone in the IVF treatment of women with poor ovarian reserve. Frontiers in Endocrinology2019;10:500.">Hart 2019</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD000099-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-FIG-01" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD000099-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included trials." data-id="CD000099-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included trials. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD000099-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Adjuvant GH compared to no adjuvant: routine use for IVF, outcome: 1.1 Live birth rate per woman randomised." data-id="CD000099-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Adjuvant GH compared to no adjuvant: routine use for IVF, outcome: 1.1 Live birth rate per woman randomised. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Growth hormone versus no adjuvant: poor responders, outcome: 2.1 Live birth rate per woman randomised." data-id="CD000099-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Growth hormone versus no adjuvant: poor responders, outcome: 2.1 Live birth rate per woman randomised. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Growth hormone versus no adjuvant: poor responders, outcome: 2.2 Pregnancy rate per woman randomised." data-id="CD000099-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Growth hormone versus no adjuvant: poor responders, outcome: 2.2 Pregnancy rate per woman randomised. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-FIG-07" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD000099-fig-0007" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-FIG-07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-FIG-08" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD000099-fig-0008" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-FIG-08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-FIG-09" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD000099-fig-0009" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-FIG-09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-FIG-10" target="_blank"><b></b></a></p> </div><img alt="Funnel plot ‐ Preganacy rate per woman randomised in poor responder group." data-id="CD000099-fig-0010" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-FIG-10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Funnel plot ‐ Preganacy rate per woman randomised in poor responder group.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-FIG-10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Adjuvant GH compared to no adjuvant: routine use for IVF, Outcome 1: Live birth rate per woman randomised" data-id="CD000099-fig-0011" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Adjuvant GH compared to no adjuvant: routine use for IVF, Outcome 1: Live birth rate per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Adjuvant GH compared to no adjuvant: routine use for IVF, Outcome 2: Clinical pregnancy rate per woman randomised" data-id="CD000099-fig-0012" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Adjuvant GH compared to no adjuvant: routine use for IVF, Outcome 2: Clinical pregnancy rate per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Adjuvant GH compared to no adjuvant: routine use for IVF, Outcome 3: Number of women with at least one oocyte retrieved per woman randomised" data-id="CD000099-fig-0013" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Adjuvant GH compared to no adjuvant: routine use for IVF, Outcome 3: Number of women with at least one oocyte retrieved per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Adjuvant GH compared to no adjuvant: routine use for IVF, Outcome 4: Mean number of oocytes retrieved" data-id="CD000099-fig-0014" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Adjuvant GH compared to no adjuvant: routine use for IVF, Outcome 4: Mean number of oocytes retrieved </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Adjuvant GH compared to no adjuvant: routine use for IVF, Outcome 5: Embryo transfer achieved per woman randomised" data-id="CD000099-fig-0015" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Adjuvant GH compared to no adjuvant: routine use for IVF, Outcome 5: Embryo transfer achieved per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Adjuvant GH compared to no adjuvant: routine use for IVF, Outcome 6: Mean units of gonadotrophin used" data-id="CD000099-fig-0016" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Adjuvant GH compared to no adjuvant: routine use for IVF, Outcome 6: Mean units of gonadotrophin used </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Adjuvant GH compared to no adjuvant: poor responders for IVF, Outcome 1: Live birth rate per woman randomised" data-id="CD000099-fig-0017" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Adjuvant GH compared to no adjuvant: poor responders for IVF, Outcome 1: Live birth rate per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Adjuvant GH compared to no adjuvant: poor responders for IVF, Outcome 2: Clinical pregnancy rate per woman randomised" data-id="CD000099-fig-0018" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Adjuvant GH compared to no adjuvant: poor responders for IVF, Outcome 2: Clinical pregnancy rate per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Adjuvant GH compared to no adjuvant: poor responders for IVF, Outcome 3: Number of women with at least one oocyte retrieved per woman randomised" data-id="CD000099-fig-0019" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Adjuvant GH compared to no adjuvant: poor responders for IVF, Outcome 3: Number of women with at least one oocyte retrieved per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Adjuvant GH compared to no adjuvant: poor responders for IVF, Outcome 4: Mean number of oocytes retrieved" data-id="CD000099-fig-0020" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Adjuvant GH compared to no adjuvant: poor responders for IVF, Outcome 4: Mean number of oocytes retrieved </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Adjuvant GH compared to no adjuvant: poor responders for IVF, Outcome 5: Embryo transfer acheived per woman randomised" data-id="CD000099-fig-0021" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Adjuvant GH compared to no adjuvant: poor responders for IVF, Outcome 5: Embryo transfer acheived per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Adjuvant GH compared to no adjuvant: poor responders for IVF, Outcome 6: Mean units gonadotropin used" data-id="CD000099-fig-0022" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Adjuvant GH compared to no adjuvant: poor responders for IVF, Outcome 6: Mean units gonadotropin used </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Adjuvant GH compared to no adjuvant: subgroup analysis based on age, Outcome 1: Live birth rate per woman randomised" data-id="CD000099-fig-0023" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Adjuvant GH compared to no adjuvant: subgroup analysis based on age, Outcome 1: Live birth rate per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Adjuvant GH compared to no adjuvant: subgroup analysis based on age, Outcome 2: Clinical pregnancy rate per woman randomised" data-id="CD000099-fig-0024" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Adjuvant GH compared to no adjuvant: subgroup analysis based on age, Outcome 2: Clinical pregnancy rate per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Adjuvant GH compared to no adjuvant: subgroup analysis based on age, Outcome 3: No of women with at least one oocyte retrieved per woman randomised" data-id="CD000099-fig-0025" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Adjuvant GH compared to no adjuvant: subgroup analysis based on age, Outcome 3: No of women with at least one oocyte retrieved per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Adjuvant GH compared to no adjuvant: subgroup analysis based on age, Outcome 4: Mean number of oocytes retrieved" data-id="CD000099-fig-0026" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Adjuvant GH compared to no adjuvant: subgroup analysis based on age, Outcome 4: Mean number of oocytes retrieved </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Adjuvant GH compared to no adjuvant: subgroup analysis based on age, Outcome 5: Embryo transfer achieved per woman randomised" data-id="CD000099-fig-0027" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Adjuvant GH compared to no adjuvant: subgroup analysis based on age, Outcome 5: Embryo transfer achieved per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000099-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/urn:x-wiley:14651858:media:CD000099:CD000099-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Adjuvant GH compared to no adjuvant: subgroup analysis based on age, Outcome 6: Mean units of gonadotropin used" data-id="CD000099-fig-0028" src="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_t/tCD000099-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Adjuvant GH compared to no adjuvant: subgroup analysis based on age, Outcome 6: Mean units of gonadotropin used </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/media/CDSR/CD000099/image_n/nCD000099-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD000099-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Adjuvant growth hormone compared to no adjuvant: routine use for in vitro fertilisation (IVF)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Adjuvant growth hormone compared to no adjuvant: routine use for in vitro fertilisation (IVF)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with infertility <br/><b>Setting:</b> IVF<br/><b>Intervention:</b> growth hormone <br/><b>Comparison:</b> no adjuvant </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants(trials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with no adjuvant: routine use</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with growth hormone</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Live birth rate per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.32<br/>(0.40 to 4.43) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>80<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of growth hormone on live birth rate per woman randomised in normal responders </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 100<br/>(6 to 43) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical pregnancy rate per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.78<br/>(0.49 to 6.50) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>42<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Only one study reported this outcome, hence conclusions cannot be drawn.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>27 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 100<br/>(16 to 71) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of women with at least one oocyte retrieved per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.86<br/>(0.11 to 74.31) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>42<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Only one study reported this outcome, hence conclusions cannot be drawn.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>95 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>98 per 100<br/>(70 to 100) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean number of oocytes retrieved</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of oocytes retrieved ranged from 6 to 13</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.02 lower<br/>(0.79 lower to 0.74 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of growth hormone on mean number of oocytes retrieved in normal responders. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Embryo transfer achieved per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 7.36<br/>(0.36 to 151.91) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>42<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Only one study reported this outcome, hence conclusions cannot be drawn.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>86 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>98 per 100<br/>(70 to 100) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean units of gonadotrophin used</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean units of gonadotrophin used ranged from 1327 to 2820 units</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 13.57 units higher<br/>(112.88 lower to 140.01 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of growth hormone on mean units of gonadotrophin used in normal responders. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a> reported: </p> <p>‐ ectopic pregnancy 0/20 in GH group and 2/22 in control group</p> <p>‐ multiple pregnancy 5/20 in GH group and 2/22 in control group</p> <p>‐ OHSS 0/20 in GH group and 0/22 in control group</p> <p><a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a> reported: </p> <p>‐ multiple pregnancy 0/19 in GH group and 1/19 in control group. Other adverse events were not reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>e,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that growth hormone does not increase or reduce adverse events in normal responders. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/><b>CI:</b> confidence interval; <b>GH</b> : growth hormone; <b>IVF</b> : in vitro fertilisation; <b>MD</b> : mean difference; <b>OR:</b> odds ratio; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to randomisation bias and selective reporting. There are only 2 trials in this analysis.<br/><sup>b</sup>Downgraded 2 levels due to imprecision, small study numbers and very wide confidence intervals.<br/><sup>c</sup>Downgraded one level due to randomisation bias and selective reporting.<br/><sup>d</sup>Only one study reported this outcome, hence downgraded.<br/><sup>e</sup>Not all outcomes reported uniformly.<br/><sup>f</sup>Small study numbers. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Adjuvant growth hormone compared to no adjuvant: routine use for in vitro fertilisation (IVF)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000099-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Adjuvant growth hormone compared to no adjuvant: poor responders for in vitro fertilisation (IVF)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Growth hormone compared to no adjuvant: poor responders for in vitro fertilisation (IVF)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with infertility subclassified as poor responders<br/><b>Setting:</b> IVF <br/><b>Intervention:</b> growth hormone <br/><b>Comparison:</b> no adjuvant </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(trials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with no adjuvant: poor responders</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with growth hormone</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Live birth rate per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.77<br/>(1.17 to 2.70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>737<br/>(8 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of growth hormone on live birth rate per woman randomised in poor responders. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 100<br/>(13 to 25) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical pregnancy rate per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.85<br/>(1.35 to 2.53) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1033<br/>(11 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Growth hormone may result in a slight increase in clinical pregnancy rate per woman randomised in poor responders. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>25 per 100<br/>(19 to 31) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of women with at least one oocyte retrieved per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 5.67<br/>(1.54 to 20.83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>148<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence suggests that growth hormone results in little to no difference in number of women with at least one oocyte retrieved per woman randomised. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>81 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>96 per 100<br/>(87 to 99) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean number of oocytes retrieved</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of oocytes retrieved ranged from 2 to 6</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1.40 higher<br/>(1.16 higher to 1.64 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1153<br/>(12 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Growth hormone may result in a slight increase in mean number of oocytes retrieved in poor responders. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Embryo transfer achieved per woman randomised</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.32<br/>(1.08 to 4.96) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>214<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of growth hormone on embryo transfer achieved per woman randomised in poor responders. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>77 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>89 per 100<br/>(78 to 94) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean units gonadotropin used</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean units gonadotropin used ranged from 2548 to 5590 units</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1088.19 units lower<br/>(1203.2 lower to 973.18 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>685<br/>(8 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests growth hormone results in a slight reduction in mean units of gonadotropin used in poor responders. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Six trials did not report adverse events (<a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a>; <a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a>; <a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a>; <a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a>; <a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a>; <a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a>). The other 8 trials reported adverse events. <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a> reported ectopic pregnancies: 0/13 in GH group and 1/12 in control; the other trials in poor responder group reported no cases of ectopic pregnancy in either group. Multiple pregnancy was reported in <a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a>: 2/13 in GH group and 0/12 in control group; <a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a> reported 1/78 in GH group and 1/78 in control group; <a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a> reported 1/10 in 4 IU GH group and 0/6 in control group; and other trials reported no cases of multiple pregnancies in either group. <a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a> reported congenital anomalies: 1/65 in GH group and 1/65 in control group; other trials reported no cases of congenital anomalies in either group. <a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a> reported that 2/29 cases in GH group had oedema, but this outcome was not reported by any other study. <a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a>, <a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a> and <a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a> reported that no adverse events were seen in either group. This information has been presented in tabular form (<a href="./full#CD000099-tbl-0003">Table 1</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>512<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>e,g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Results reported varied across the studies, from an increase to a decrease of AEs with use of GH, but the evidence is very uncertain. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/><b>CI:</b> confidence interval; <b>IVF</b> : in vitro fertilisation; <b>MD</b> : mean difference; <b>OR:</b> odds ratio; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of attrition bias.<br/><sup>b</sup>Downgraded one level due to imprecision, small numbers and wide confidence intervals.<br/><sup>c</sup>Downgraded one level due to publication bias as per funnel plot.<br/><sup>d</sup>Downgraded one level due to randomisation bias and selective reporting.<br/><sup>e</sup>The dose, form, timing of administration was inconsistent across various trials.<br/><sup>f</sup>Downgraded one level due to allocation bias and selective reporting.<br/><sup>g</sup>Adverse events have not been reported by all trials, and the ones reporting have not reported adverse events long term. In particular effects on developing foetus have only been reported by one study. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Adjuvant growth hormone compared to no adjuvant: poor responders for in vitro fertilisation (IVF)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD000099-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Adverse events</span></div> <tbody> <tr> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Trial</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Response type</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>AE reported</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Ectopic</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Multiple</b> <br/><b>pregnancy</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Congenital</b> <br/><b>anomalies</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>OHSS</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Oedema</b> </p> </th> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GH</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GH</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GH</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GH</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GH</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>2/29</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>1/78</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>1/78</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>1/65</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>1/65</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0/13</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>1/12</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>2/13</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0/12</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>1/10<br/>(4IU group) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/6</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Normal</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>1/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Normal</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>Yes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0/20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>2/22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>5/20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>2/22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0/20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0/22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p><a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"></td> </tr> </tbody> <tfoot> <tr> <td colspan="13"> <div class="table-footnote"> <p> <ul id="CD000099-list-0001"> <li> <p>IU: international units</p> </li> <li> <p>AE: adverse effects</p> </li> <li> <p>OHSS: ovarian hyperstimulation syndrome</p> </li> </ul> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD000099-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Trial characteristics</span></div> <tbody> <tr> <th align="center" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Trial</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Age</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Poor response type</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>GH</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Dose</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Schedule</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Placebo</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>ET day</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>GH</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Total</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>BMI</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Protocol</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Control</b> </p> </th> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000099-bbs2-0001" title="BerghC , CarlstromK , SelleskogU , HillensjoT . Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization. European Journal of Endocrinology1996;134:190-6. BerghC , NilssonL , HillensjoT , BorgG , WiklandM , HamgergerL . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility and Sterility1994;62:113-20. ">Bergh 1994</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 38</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Response x 2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1 IU/kg</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pre‐ treatment for 7 days followed by with/without stimulation</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Saline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Day 2/3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 x 4 groups</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0002" title="ChoeS , KimMJ , LeeHJ , LeeWS , YoonTK , KimYS , et al. Increased proportion of mature oocytes with sustained release growth hormone treatment in poor responders: a prospective randomised controlled study. Archives of Gynecology and Obstetrics2017;297(3):791-6. KimYS , YoonTK , KimJW , KimMJ , KimJ , ChoeSA , et al. Increased proportion of mature oocytes with sustained releasing growth hormone treatment in poor responders: a randomized controlled study. Human reproduction (Oxford, England) abstract from 33rd Annual Meeting of the European Society of Human Reproduction and Embryology2017;32(0):i464-5. ">Choe 2017</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 40</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Bologna</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Sustained‐release GH</p> <p>Antagonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>20 mg</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3 doses ‐ previous cycle mid luteal, late luteal and D2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not stated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>62</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>127</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 30</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0003" title="DakhlyD , BassiounyYA , BayoumiYA , HassanMA , GoudaHM , HassanAA . The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomised control trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2018;228:161-5. ">Dakhly 2018</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>≥ 40</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Bologna</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>7.5 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Daily from D21 of previous cycle</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 3 up to 3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>120</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>240</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>120</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0004" title="DorJ , SeidmanDS , AmudaiE , BiderD , LevranD , MashiachS . Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double blind study. Human Reproduction1995;10(1):40-3. ">Dor 1995</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Response</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Flare</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>18 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Days 2, 4, 6, 8</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Mannitol</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>14</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0005" title="HazoutA , JuncaAM . A pilot, prospective, randomised, double blind, placebo-controlled study to compare protocols for ovarian stimulation with r-hRSH (Gonal-F) combined with two different doses of r-hGH or placebo in patients with oocyte dysmorphy undergoing ICSI. Human Reproduction2003;18(Suppl 1):299-312. ">Hazout 2003</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 39</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Oocyte dysmorphia<br/>&gt; 50% </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3 groups 4 IU, 8 IU, placebo</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Daily from day 1 of stimulation until trigger</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Yes ‐ not stated what</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>4 IU: 12</p> <p>8 IU: 11</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>35</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0006" title="KucukT , KozinogluH , KabaA . Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response:a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics2008;25:123-7. ">Kucuk 2008</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Response</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>12 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Daily from D21 of previous cycle</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>31</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>61</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0007" title="LeeYX , ShenMS , TzengCR . Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders. Frontiers in Endocrinology2019;10:892. ">Lee 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>≥ 40</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Bologna</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist ultra‐long protocol</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>4 IU, 4 IU, 2 IU ‐ total 10 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3 consecutive days with stimulation</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>94</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>184</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0008" title="MohammadEH , Abou El SerourAG , MohamedEA , AbbasyAH , ZaatarM , RagehKA , et al. Efficacy of growth hormone supplementation with gonadotropins in IVF/ICSI for poor responders: randomised controlled trial. Current Science International2019;8(3):585-94. ">Mohammad 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>25‐38</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Response</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Antagonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>4 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>D2 until 1 day before egg collection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Saline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 2/3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>78</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>156</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0009" title="NormanRJ , AlvinoH , HartR , RombautsL , LIGHT Investigators. A randomised double blind placebo controlled trial of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Human Reproduction (Oxford, England)2016;31(Suppl 1):i37. NormanRJ , AlvinoH , HullLM , MolBW , HartRJ , Kelly T-L, et al. Human growth hormone for poor responders: a randomised placebo-controlled trial provides no evidence for improved live birth rate. Reproductive BioMedicine Online2019;00:1-8. ">Norman 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 41</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Response</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Antagonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>12 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>D1 until 1 day before egg collection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Metacresol in water</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not stated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>65</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>130</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 33</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0010" title="JacobsHS . Growth hormone and ovulation: Is there an indication for treatment of infertile women with growth hormone?Hormone Research1992;38:14-21. OwenEJ , OstergaardH , ShohamZ , JacobsHS , MasonBA . Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility1991;56:1104-10. ">Owen 1991</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 38</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Response</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>24 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Alternate day from D1 stimulation<br/>(maximum 2 weeks) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Yes ‐ not stated what</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 2 (1‐4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>13</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>25</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0011" title="SafdarianL , AghahosseiniM , AlyasinA , Samaei-NourooziA , RashidiS , Shabani-NashtaeiM , et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pacific Journal for Cancer Prevention2019;20(7):2033-7. ">Safdarian 2019</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Bologna</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Antagonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3 groups: <br/>7.5 IU from day 8 <br/>0.3 IU from day 3 previous cycle <br/>saline from day 8 </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3 groups: <br/>7.5 IU from day 8 X 5 d </p> <p>0.3 IU from day 3 previous cycle x 20 d</p> <p>saline from day 8 X 5 d</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Saline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 5 up to 3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group 1: 34</p> <p>Group 2: 32</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>105</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group 3: 26</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0012" title="SuikkariAM , MacLachlanV , KoistinenR , SeppäläM , HealyDL . Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility and Sterility1996;65(4):800-5. ">Suikkari 1996</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 40</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Response x 2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Flare</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3 groups 4 IU, 12 IU, placebo</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Daily from day 3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Saline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>4 IU: 10</p> <p>12 IU: 6</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>22</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 27</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0013" title="TapanainenJ , OravaM , MartikainenH , RuokonenA , VoutilainenR , RonnbergL . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertility and Sterility1992;58:726-32. ">Tapanainen 1992</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>27‐37</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>N</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Flare</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>24 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Alternate day from D4 stimulation until last HMG</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Saline</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not stated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>38</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0014" title="TesarikJ , HazoutA , MendozaC . Improvement of delivery and live birth rates after ICSI in women aged &gt; 40 years by ovarian co-stimulation with growth hormone. Human Reproduction2005;20(9):2536-41. ">Tesarik 2005</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&gt; 40</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>As per study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>8 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Daily from D7 of stimulation until 1 day before egg collection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Yes ‐ not stated what</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Day 3 (1‐5)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>50</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>100</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0015" title="YounisJS , DorembusD , SimonA , SchenkerJG , KorenR , LauferN . The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study. Fertility and Sterility1992;58:575-80. YounisJS , EzraY , Brzezinnski, FibichT , SchenkerJG , LauferN . The effect of growth hormone on granulosa cell function during in-vitro fertilization. Human Reproduction1993;8(10):1588-92. ">Younis 1992</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>&lt; 38</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>N</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>12 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Days 1, 3, 5, 7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Mannitol</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not stated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>42</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD000099-bbs2-0016" title="ZhuangGL , WongSX , ZhouCQ . The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynaecology)1994;29(8):471-4. ">Zhuang 1994</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Response</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>HGH</p> <p>Agonist</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>12 IU</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Alternate day</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>No</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not stated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="bottom"> <p>12</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>27</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p> <ul id="CD000099-list-0009"> <li> <p>HMG: human menopausal gonadotropin</p> </li> <li> <p>IU: international units</p> </li> <li> <p>HGH: human recombinant growth hormone</p> </li> <li> <p>GH: growth hormone</p> </li> </ul> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Trial characteristics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/full#CD000099-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000099-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Adjuvant GH compared to no adjuvant: routine use for IVF</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Live birth rate per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.40, 4.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Clinical pregnancy rate per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.78 [0.49, 6.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Number of women with at least one oocyte retrieved per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.86 [0.11, 74.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Mean number of oocytes retrieved <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.79, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Embryo transfer achieved per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.36 [0.36, 151.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Mean units of gonadotrophin used <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.57 [‐112.88, 140.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Adjuvant GH compared to no adjuvant: routine use for IVF</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000099-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Adjuvant GH compared to no adjuvant: poor responders for IVF</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Live birth rate per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>737</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.77 [1.17, 2.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Poor responder by definition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.85 [1.02, 3.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Poor responder based on previous response</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>337</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [0.95, 3.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Clinical pregnancy rate per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.85 [1.35, 2.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Poor responder by definition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>711</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [1.16, 2.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Poor responder based on previous response</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>322</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.19 [1.26, 3.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Number of women with at least one oocyte retrieved per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.67 [1.54, 20.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Poor responder based on previous response</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.67 [1.54, 20.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Mean number of oocytes retrieved <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [1.16, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Poor responder based on definition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>721</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [1.12, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Poor responder based on previous response</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>432</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.96, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Embryo transfer acheived per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.32 [1.08, 4.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Poor responder based on previous response</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.32 [1.08, 4.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Mean units gonadotropin used <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>685</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1088.19 [‐1203.20, ‐973.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 Poor responder based on definition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1246.99 [‐1388.24, ‐1105.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.2 Poor responder based on previous response</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐775.79 [‐973.90, ‐577.67]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Adjuvant GH compared to no adjuvant: poor responders for IVF</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000099-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Adjuvant GH compared to no adjuvant: subgroup analysis based on age</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Live birth rate per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>817</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.62 [1.07, 2.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Age &lt; 40 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.82, 2.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 Age &gt; 40 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>340</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.69 [0.90, 3.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.3 Age criteria not defined</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.58, 15.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Clinical pregnancy rate per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1087</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.87 [1.38, 2.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Age &lt; 40 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.98 [1.12, 3.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 Age &gt; 40 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.64 [1.11, 2.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.3 Age criteria not defined</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.15 [1.25, 7.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 No of women with at least one oocyte retrieved per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.19 [1.56, 17.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 Age &lt; 40 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.19 [1.56, 17.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Mean number of oocytes retrieved <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.04, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 Age &lt; 40 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.34, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.2 Age &gt; 40 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [1.03, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.3 Age criteria not defined</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.12 [1.55, 2.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Embryo transfer achieved per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.50 [1.24, 5.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.1 Age &lt; 40 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.73 [0.80, 3.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.2 Age criteria not defined</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>23.80 [1.31, 433.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 Mean units of gonadotropin used <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>765</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐589.38 [‐674.47, ‐504.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.1 Age &lt; 40 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐24.30 [‐145.14, 96.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.2 Age &gt; 40 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐782.66 [‐1004.35, ‐560.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.3 Age criteria not defined</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1294.15 [‐1436.54, ‐1151.77]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Adjuvant GH compared to no adjuvant: subgroup analysis based on age</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000099.pub4/references#CD000099-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD000099.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD000099-note-0019">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD000099-note-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD000099-note-0017">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD000099-note-0015">Hrvatski</a> </li> <li class="section-language"> <a class="" href="hu#CD000099-note-0018">Magyar</a> </li> <li class="section-language"> <a class="" href="ja#CD000099-note-0014">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD000099-note-0013">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD000099-note-0012">Português</a> </li> <li class="section-language"> <a class="" href="th#CD000099-note-0011">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD000099-note-0009">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD000099-note-0010">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000099\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000099\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000099\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000099\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000099\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=QO4KtYGW&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000099.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000099.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD000099.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD000099.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000099.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728059666"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000099.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728059670"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000099.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ebb3dafd8f498',t:'MTc0MDcyODA2MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 